<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Alzheimer's disease,1906,1970s,1980s,2002,2006,2007,Acetylcholine,Acetylcholinesterase,Activities of daily living,Adult Neurogenesis" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Alzheimer's disease - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Alzheimer's disease</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table class="infobox" style="width: 200px; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Alzheimer's disease</b><br />
<i>Classification &amp; external resources</i></caption>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><span><a href="../../../a/l/z/Image%7EAlzheimer_dementia_%283%29_presenile_onset.jpg_f9bc.html" class="image" title=""><img src="../../../upload/shared/thumb/a/a7/Alzheimer_dementia_%283%29_presenile_onset.jpg/190px-Alzheimer_dementia_%283%29_presenile_onset.jpg" alt="" width="190" height="143" longdesc="../../../a/l/z/Image%7EAlzheimer_dementia_%283%29_presenile_onset.jpg_f9bc.html" /></a></span></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>Histopathologic image of senile plaques seen in the cerebral cortex in a patient with Alzheimer disease of presenile onset. Silver impregnation.</small></td>
</tr>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-10_codes_1183.html" title="List of ICD-10 codes">10</a></th>
<td><a href="../../../i/c/d/ICD-10_Chapter_G_2319.html" title="ICD-10 Chapter G">G</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gg30.htm+g30" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gg30.htm+g30" rel="nofollow">30.</a>, <a href="../../../i/c/d/ICD-10_Chapter_F_2a65.html" title="ICD-10 Chapter F">F</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gf00.htm+f00" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gf00.htm+f00" rel="nofollow">00.</a></td>
</tr>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-9_codes_cdaa.html" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=331.0" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=331.0" rel="nofollow">331.0</a>, <a href="http://www.icd9data.com/getICD9Code.ashx?icd9=290.1" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=290.1" rel="nofollow">290.1</a></td>
</tr>
<tr>
<th><a href="../../../o/m/i/OMIM_6457.html" title="OMIM">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=104300" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=104300" rel="nofollow">104300</a></td>
</tr>
<tr>
<th><a href="../../../d/i/s/Diseases_Database_9859.html" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb490.htm" class="external text" title="http://www.diseasesdatabase.com/ddb490.htm" rel="nofollow">490</a></td>
</tr>
<tr>
<th><a href="../../../m/e/d/MedlinePlus_0b70.html" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000760.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000760.htm" rel="nofollow">000760</a></td>
</tr>
<tr>
<th><a href="../../../e/m/e/EMedicine_a89c.html" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/neuro/topic13.htm" class="external text" title="http://www.emedicine.com/neuro/topic13.htm" rel="nofollow">neuro/13</a>&#160;</td>
</tr>
</table>
<p><b>Alzheimer's disease</b> (<b>AD</b>), also known simply as <b>Alzheimer's</b>, is a <a href="../../../n/e/u/Neurodegenerative_disease.html" title="Neurodegenerative disease">neurodegenerative disease</a> characterized by progressive cognitive deterioration together with declining activities of daily living and <a href="../../../n/e/u/Neuropsychology.html" title="Neuropsychology">neuropsychiatric</a> symptoms or behavioral changes. It is the most common type of <a href="../../../d/e/m/Dementia.html" title="Dementia">dementia</a>.</p>
<p>The most striking early symptom is loss of short-term memory (<a href="../../../a/m/n/Amnesia.html" title="Amnesia">amnesia</a>), which usually manifests as minor forgetfulness that becomes steadily more pronounced with illness progression, with relative preservation of older memories. As the disorder progresses, cognitive (intellectual) impairment extends to the domains of language (<a href="../../../a/p/h/Aphasia.html" title="Aphasia">aphasia</a>), skilled movements (<a href="../../../a/p/r/Apraxia.html" title="Apraxia">apraxia</a>), recognition (<a href="../../../a/g/n/Agnosia.html" title="Agnosia">agnosia</a>), and those functions (such as <a href="../../../d/e/c/Decision-making.html" title="Decision-making">decision-making</a> and planning) closely related to the frontal and temporal lobes of the brain as they become disconnected from the <a href="../../../l/i/m/Limbic_system.html" title="Limbic system">limbic system</a>, reflecting extension of the underlying pathological process. This pathological process consists principally of <a href="../../../n/e/u/Neuron.html" title="Neuron">neuronal</a> loss or <a href="../../../a/t/r/Atrophy.html" title="Atrophy">atrophy</a>, principally in the temporoparietal cortex, but also in the frontal cortex, together with an inflammatory response to the deposition of <a href="../../../a/m/y/Amyloid.html" title="Amyloid">amyloid plaques</a> and <a href="../../../n/e/u/Neurofibrillary_tangles.html" title="Neurofibrillary tangles">neurofibrillary tangles</a>.</p>
<p>The ultimate cause of the disease is unknown. Genetic factors are known to be important, and dominant <a href="../../../m/u/t/Mutations.html" title="Mutations">mutations</a> in three different genes have been identified that account for a much smaller number of cases of <a href="../../../f/a/m/Familial_Alzheimer_disease_8838.html" title="Familial Alzheimer disease">familial, early-onset AD</a>. For the more common form of late onset AD (LOAD), <a href="../../../a/p/o/Apolipoprotein_E_69c9.html" title="Apolipoprotein E">ApoE</a> is the only repeatibly confirmed susceptibility genes for AD. In 2007, evidence suggested a possible association between <a href="../../../s/o/r/Sortilin-related_receptor%2C_L%28DLR_class%29_A_repeats-containing_3872.html" title="Sortilin-related receptor, L(DLR class) A repeats-containing">SORL1</a> alleles and AD.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Clinical_features"><span class="tocnumber">2</span> <span class="toctext">Clinical features</span></a>
<ul>
<li class="toclevel-2"><a href="#Stages_and_symptoms"><span class="tocnumber">2.1</span> <span class="toctext">Stages and symptoms</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Pathology"><span class="tocnumber">4</span> <span class="toctext">Pathology</span></a>
<ul>
<li class="toclevel-2"><a href="#Biochemical_characteristics"><span class="tocnumber">4.1</span> <span class="toctext">Biochemical characteristics</span></a></li>
<li class="toclevel-2"><a href="#Neuropathology"><span class="tocnumber">4.2</span> <span class="toctext">Neuropathology</span></a></li>
<li class="toclevel-2"><a href="#Disease_mechanism"><span class="tocnumber">4.3</span> <span class="toctext">Disease mechanism</span></a></li>
<li class="toclevel-2"><a href="#Genetics"><span class="tocnumber">4.4</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-2"><a href="#Genetic_linkage"><span class="tocnumber">4.5</span> <span class="toctext">Genetic linkage</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Epidemiology_and_prevention"><span class="tocnumber">5</span> <span class="toctext">Epidemiology and prevention</span></a>
<ul>
<li class="toclevel-2"><a href="#Risk_reducers"><span class="tocnumber">5.1</span> <span class="toctext">Risk reducers</span></a></li>
<li class="toclevel-2"><a href="#Risk_factors"><span class="tocnumber">5.2</span> <span class="toctext">Risk factors</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Acetylcholinesterase_inhibitors"><span class="tocnumber">6.1</span> <span class="toctext">Acetylcholinesterase inhibitors</span></a></li>
<li class="toclevel-2"><a href="#Gingko_biloba"><span class="tocnumber">6.2</span> <span class="toctext">Gingko biloba</span></a></li>
<li class="toclevel-2"><a href="#NMDA_antagonists"><span class="tocnumber">6.3</span> <span class="toctext">NMDA antagonists</span></a></li>
<li class="toclevel-2"><a href="#Psychosocial_interventions"><span class="tocnumber">6.4</span> <span class="toctext">Psychosocial interventions</span></a></li>
<li class="toclevel-2"><a href="#Treatments_in_clinical_development"><span class="tocnumber">6.5</span> <span class="toctext">Treatments in clinical development</span></a></li>
<li class="toclevel-2"><a href="#Occupational_and_lifestyle_therapies"><span class="tocnumber">6.6</span> <span class="toctext">Occupational and lifestyle therapies</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Social_issues"><span class="tocnumber">7</span> <span class="toctext">Social issues</span></a></li>
<li class="toclevel-1"><a href="#Statistics_on_Alzheimer.27s_disease"><span class="tocnumber">8</span> <span class="toctext">Statistics on Alzheimer's disease</span></a></li>
<li class="toclevel-1"><a href="#Notable_cases"><span class="tocnumber">9</span> <span class="toctext">Notable cases</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="../../../a/u/g/Image%7EAuguste_D_aus_Marktbreit.jpg_30f1.html" class="internal" title="Auguste D."><img src="../../../upload/shared/thumb/1/1d/Auguste_D_aus_Marktbreit.jpg/180px-Auguste_D_aus_Marktbreit.jpg" alt="Auguste D." width="180" height="182" longdesc="../../../a/u/g/Image%7EAuguste_D_aus_Marktbreit.jpg_30f1.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../a/u/g/Image%7EAuguste_D_aus_Marktbreit.jpg_30f1.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="../../../a/u/g/Auguste_D_619b.html" title="Auguste D">Auguste D</a>.</div>
</div>
</div>
<p>In 1901, Dr. <a href="../../../a/l/o/Alois_Alzheimer_d957.html" title="Alois Alzheimer">Alois Alzheimer</a>, a German psychiatrist, interviewed a patient named Mrs. <a href="../../../a/u/g/Auguste_D_619b.html" title="Auguste D">Auguste D</a>., age 51. She was brought in by her husband, Karl Deter, who could not care for her declining mental health any longer. Dr. Alzheimer showed her several objects and later asked her what she had been shown. She could not recall. He would initially record her behavior as "amnesic writing disorder," but Mrs. Auguste D would be the first patient to be identified with Alzheimer's disease.</p>
<p>Alzheimer would later work in the laboratory of the preeminent <a href="../../../e/m/i/Emil_Kraepelin_fa61.html" title="Emil Kraepelin">Emil Kraepelin</a> in <a href="../../../m/u/n/Munich%2C_Germany_0a92.html" title="Munich, Germany">Munich, Germany</a>. Kraepelin was the author of a leading textbook in psychiatry and was a strong believer that neuropathology could be linked to clinical psychiatric function. Early in April 1906, Auguste D. died, and Alzheimer worked with two Italian physicians to examine her anatomy and neuropathology. On <a href="../../../n/o/v/November_3.html" title="November 3">November 3</a>, <a href="../../../1/9/0/1906.html" title="1906">1906</a>, he presented Auguste D.'s case to the 37th Assembly of Southwest German Psychiatrists and described the neurofibrillary tangles and amyloid plaques that have come to be considered the hallmark of the disease. Kraepelin would later write about this case and others in his "Textbook for Students and Doctors" and index them under "Alzheimer's disease". By 1910, this denomination for the disease was well established among the specialist community.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup></p>
<p>For most of the twentieth century, the diagnosis of Alzheimer's disease was reserved for individuals between the ages of 45-65 who developed symptoms of <i>presenile</i> <a href="../../../d/e/m/Dementia.html" title="Dementia">dementia</a> due to the histopathologic process discovered by Dr. Alzheimer (see below for description of brain tissue changes). During this time <i>senile dementia</i> itself (as a set of symptoms) was considered to be a more or less normal outcome of the aging process, and thought to be due to age-related brain arterial "hardening." In the <a href="../../../1/9/7/1970s.html" title="1970s">1970s</a> and early-<a href="../../../1/9/8/1980s.html" title="1980s">1980s</a>, because the symptoms and brain pathology were identical for Alzheimer victims older and younger than age 65, the name "Alzheimer's disease" began to be used, within and outside the medical profession, equally for afflicted individuals of all ages, although in this period the term <i>senile dementia of the Alzheimer type</i> (SDAT) was often used to distinguish those over 65 who did not fit the classical age criterion. Eventually, the term Alzheimer's disease was adopted formally in the psychiatric and neurological nomenclature to describe individuals of all ages with the characteristic common symptom pattern, disease course, and neuropathology. The term <i>Alzheimer disease</i> (without the apostrophe and s) also continues to be used commonly in the literature.</p>
<p><a name="Clinical_features" id="Clinical_features"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Clinical features">edit</a>]</span> <span class="mw-headline">Clinical features</span></h2>
<p>The usual first symptom noticed is short term memory loss which progresses from seemingly simple and often fluctuating <a href="../../../f/o/r/Forgetfulness.html" title="Forgetfulness">forgetfulness</a> (with which the disease should not be confused) to a more pervasive loss of <a href="../../../s/h/o/Short-term_memory.html" title="Short-term memory">short-term memory</a>, then of familiar and well-known skills or objects or persons. <a href="../../../a/p/h/Aphasia.html" title="Aphasia">Aphasia</a>, <a href="../../../d/i/s/Disorientation.html" title="Disorientation">disorientation</a> and <a href="../../../d/i/s/Disinhibition.html" title="Disinhibition">disinhibition</a> often accompany the loss of memory. Alzheimer's disease may also include behavioral changes, such as outbursts of <a href="../../../v/i/o/Violence.html" title="Violence">violence</a> or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and <a href="../../../i/n/c/Incontinence.html" title="Incontinence">incontinence</a>, will be seen if death from some external cause (e.g. <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">heart attack</a> or <a href="../../../p/n/e/Pneumonia.html" title="Pneumonia">pneumonia</a>) does not intervene. Average duration of the disease is approximately 7–10 years, although cases are known where reaching the final stage occurs within 4–5 years, or in some reported cases up to 21 years.</p>
<p><a name="Stages_and_symptoms" id="Stages_and_symptoms"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Stages and symptoms">edit</a>]</span> <span class="mw-headline">Stages and symptoms</span></h3>
<ul>
<li><b>Mild</b> — At the <b>early stage</b> of the disease, patients have a tendency to become less energetic or spontaneous, though changes in their behavior often go unnoticed even by the patients' immediate family. This stage of the disease has also been termed Mild Cognitive Impairment (MCI) although this term remains somewhat controversial <sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup>.</li>
<li><b>Moderate</b> — As the disease progresses to the <b>middle stage</b>, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities.</li>
<li><b>Severe</b> — As the disease progresses from the middle to <b>late stage</b>, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.</li>
</ul>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>The diagnosis is made primarily on the basis of history, clinical observation, memory tests and intellectual functioning over a series of weeks or months, with various physical tests (<a href="../../../b/l/o/Blood_test.html" title="Blood test">blood tests</a> and <a href="../../../n/e/u/Neuroimaging.html" title="Neuroimaging">neuroimaging</a>) being performed to rule out alternative diagnoses. No medical tests are available to diagnose Alzheimer's disease conclusively pre-mortem. Expert clinicians who specialize in memory disorders can now diagnose AD with an accuracy of 85–90%, but a definitive diagnosis of Alzheimer's disease must await microscopic examination of brain tissue, generally at <a href="../../../a/u/t/Autopsy.html" title="Autopsy">autopsy</a>. Functional neuroimaging studies such as <a href="../../../p/o/s/Positron_emission_tomography.html" title="Positron emission tomography">PET</a> and <a href="../../../s/p/e/SPECT_c65e.html" title="SPECT">SPECT</a> scans can provide a supporting role where dementia is clearly present, but the type of dementia is questioned. Recent studies suggest that SPECT neuroimaging approaches clinical exam in diagnostic accuracy and may outperform exam at differentiating types of dementia (Alzheimer's disease vs. vascular dementia).<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup><sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup> However, Alzheimer's disease remains a primarily clinical diagnosis based on the presence of characteristic neurological features and the absence of alternative diagnoses, with possible neuroimaging assistance. Interviews with family members and/or caregivers are extremely important in the initial assessment, as the sufferer him/herself may tend to minimize his symptomatology or may undergo evaluation at a time when his/her symptoms are less apparent, as quotidian fluctuations ("good days and bad days") are a fairly common feature. Such interviews also provide important information on the affected individual's functional abilities, which are a key indicator of the significance of the symptoms and the stage of dementia.</p>
<p>Initial suspicion of dementia may be strengthened by performing the <a href="../../../m/i/n/Mini_mental_state_examination.html" title="Mini mental state examination">mini mental state examination</a>, after excluding <a href="../../../c/l/i/Clinical_depression.html" title="Clinical depression">clinical depression</a>. Psychological testing generally focuses on memory, attention, abstract thinking, the ability to name objects, visuospatial abilities, and other cognitive functions. Results of psychological tests may not readily distinguish Alzheimer's disease from other types of dementia, but can be helpful in establishing the presence of and severity of dementia. They can also be useful in distinguishing true dementia from temporary (and more treatable) cognitive impairment due to depression or psychosis, which has sometimes been termed "pseudodementia". In addition, a 2004 study by Cervilla and colleagues showed that tests of cognitive ability provide useful predictive information up to a decade before the onset of dementia.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[6]</a></sup> However, when diagnosing individuals with a higher level of cognitive ability, in this study those with <a href="../../../i/q/_/IQ_560e.html" title="IQ">IQs</a> of 120 or more,<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[7]</a></sup> patients should not be diagnosed from the standard norm but from an adjusted high-I.Q norm that measured changes against the individual's higher ability level.</p>
<p><a name="Pathology" id="Pathology"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Pathology">edit</a>]</span> <span class="mw-headline">Pathology</span></h2>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="../../../b/i/o/Biochemistry_of_Alzheimer%27s_disease_9146.html" title="Biochemistry of Alzheimer's disease">Biochemistry of Alzheimer's disease</a></i></div>
</dd>
</dl>
<p><a name="Biochemical_characteristics" id="Biochemical_characteristics"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Biochemical characteristics">edit</a>]</span> <span class="mw-headline">Biochemical characteristics</span></h3>
<p>Alzheimer's disease has been identified as a <a href="../../../p/r/o/Protein_folding.html" title="Protein folding">protein misfolding</a> disease, or <a href="../../../p/r/o/Proteopathy.html" title="Proteopathy">proteopathy</a>, due to the accumulation of abnormally folded <a href="../../../a/m/y/Amyloid_beta.html" title="Amyloid beta">amyloid beta</a> protein in the brains of AD patients.<sup id="_ref-Hashimoto_0" class="reference"><a href="#_note-Hashimoto" title="">[8]</a></sup> Amyloid beta, also written Aβ, is a short <a href="../../../p/e/p/Peptide.html" title="Peptide">peptide</a> that is a <a href="../../../p/r/o/Proteolysis.html" title="Proteolysis">proteolytic</a> byproduct of the <a href="../../../t/r/a/Transmembrane_protein.html" title="Transmembrane protein">transmembrane protein</a> <a href="../../../a/m/y/Amyloid_precursor_protein.html" title="Amyloid precursor protein">amyloid precursor protein</a> (APP), whose function is unclear but thought to be involved in neuronal development.<sup id="_ref-Kerr_0" class="reference"><a href="#_note-Kerr" title="">[9]</a></sup> The <a href="../../../p/r/e/Presenilin.html" title="Presenilin">presenilins</a> are components of proteolytic complex involved in APP processing and degradation.<sup id="_ref-Cai_0" class="reference"><a href="#_note-Cai" title="">[10]</a></sup> Although amyloid beta <a href="../../../m/o/n/Monomer.html" title="Monomer">monomers</a> are soluble and harmless, they undergo a dramatic <a href="../../../c/o/n/Conformational_change.html" title="Conformational change">conformational change</a> at sufficiently high concentration to form a <a href="../../../b/e/t/Beta_sheet.html" title="Beta sheet">beta sheet</a>-rich <a href="../../../t/e/r/Tertiary_structure.html" title="Tertiary structure">tertiary structure</a> that aggregates to form <a href="../../../a/m/y/Amyloid.html" title="Amyloid">amyloid fibrils</a><sup id="_ref-Ohnishi_0" class="reference"><a href="#_note-Ohnishi" title="">[11]</a></sup> that deposit outside neurons in dense formations known as <i>senile plaques</i> or <i>neuritic plaques</i>, in less dense aggregates as <i>diffuse plaques</i>, and sometimes in the walls of small blood vessels in the brain in a process called amyloid angiopathy or <a href="../../../c/o/n/Congophilic_angiopathy.html" title="Congophilic angiopathy">congophilic angiopathy</a>.</p>
<p>AD is also considered a <a href="../../../t/a/u/Tauopathy.html" title="Tauopathy">tauopathy</a> due to abnormal aggregation of the <a href="../../../t/a/u/Tau_protein.html" title="Tau protein">tau protein</a>, a <a href="../../../m/i/c/Microtubule-associated_protein.html" title="Microtubule-associated protein">microtubule-associated protein</a> expressed in neurons that normally acts to stabilize <a href="../../../m/i/c/Microtubules.html" title="Microtubules">microtubules</a> in the cell <a href="../../../c/y/t/Cytoskeleton.html" title="Cytoskeleton">cytoskeleton</a>. Like most microtubule-associated proteins, tau is normally regulated by <a href="../../../p/h/o/Phosphorylation.html" title="Phosphorylation">phosphorylation</a>; however, in AD patients, hyperphosphorylated tau accumulated as paired helical filaments<sup id="_ref-Goedert_0" class="reference"><a href="#_note-Goedert" title="">[12]</a></sup> that in turn aggregate into masses inside nerve cell bodies known as <i>neurofibrillary tangles</i> and as dystrophic <a href="../../../n/e/u/Neurite.html" title="Neurite">neurites</a> associated with amyloid plaques.</p>
<p><a name="Neuropathology" id="Neuropathology"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Neuropathology">edit</a>]</span> <span class="mw-headline">Neuropathology</span></h3>
<p>Both amyloid plaques and neurofibrillary tangles are clearly visible by <a href="../../../m/i/c/Microscopy.html" title="Microscopy">microscopy</a> in AD brains.<sup id="_ref-Tiraboschi_0" class="reference"><a href="#_note-Tiraboschi" title="">[13]</a></sup> At an anatomical level, AD is characterized by gross diffuse atrophy of the brain and loss of neurons, neuronal processes and synapses in the <a href="../../../c/e/r/Cerebral_cortex.html" title="Cerebral cortex">cerebral cortex</a> and certain subcortical regions. This results in gross <a href="../../../a/t/r/Atrophy.html" title="Atrophy">atrophy</a> of the affected regions, including degeneration in the <a href="../../../t/e/m/Temporal_lobe.html" title="Temporal lobe">temporal lobe</a> and <a href="../../../p/a/r/Parietal_lobe.html" title="Parietal lobe">parietal lobe</a>, and parts of the <a href="../../../f/r/o/Frontal_cortex.html" title="Frontal cortex">frontal cortex</a> and <a href="../../../c/i/n/Cingulate_gyrus.html" title="Cingulate gyrus">cingulate gyrus</a>.<sup id="_ref-Wenk_0" class="reference"><a href="#_note-Wenk" title="">[14]</a></sup> Levels of the neurotransmitter <a href="../../../a/c/e/Acetylcholine.html" title="Acetylcholine">acetylcholine</a> are reduced. Levels of the neurotransmitters <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a>, <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a>, and <a href="../../../s/o/m/Somatostatin.html" title="Somatostatin">somatostatin</a> are also often reduced. <a href="../../../g/l/u/Glutamate.html" title="Glutamate">Glutamate</a> levels are usually elevated.<sup id="_ref-7" class="reference"><a href="#_note-7" title="">[15]</a></sup></p>
<p><a name="Disease_mechanism" id="Disease_mechanism"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Disease mechanism">edit</a>]</span> <span class="mw-headline">Disease mechanism</span></h3>
<p>Three major competing hypotheses exist to explain the cause of the disease. The oldest, on which most currently available drug therapies are based, is known as the "<a href="../../../c/h/o/Cholinergic.html" title="Cholinergic">cholinergic</a> hypothesis" and suggests that AD begins as a deficiency in the production of the <a href="../../../n/e/u/Neurotransmitter.html" title="Neurotransmitter">neurotransmitter</a> <a href="../../../a/c/e/Acetylcholine.html" title="Acetylcholine">acetylcholine</a>. The medications that treat acetylcholine deficiency have served to only treat symptoms of the disease and have neither halted nor reversed it. The cholinergic hypothesis has not maintained widespread support in the face of this evidence, although cholingeric effects have been proposed to initiate large-scale aggregation<sup id="_ref-Shen_0" class="reference"><a href="#_note-Shen" title="">[16]</a></sup> leading to generalized neuroinflammation.<sup id="_ref-Wenk_1" class="reference"><a href="#_note-Wenk" title="">[14]</a></sup></p>
<p>Research after 2000 includes hypotheses centered on the effects of the misfolded and aggregated proteins, amyloid beta and tau. The two positions differ with one stating that the <a href="../../../t/a/u/Tau_protein.html" title="Tau protein">tau protein</a> abnormalities initiate the disease cascade, while the other believes that <a href="../../../b/e/t/Beta_amyloid.html" title="Beta amyloid">beta amyloid</a> deposits are the causative factor in the disease.<sup id="_ref-Mudher_0" class="reference"><a href="#_note-Mudher" title="">[17]</a></sup> The tau hypothesis is supported by the long-standing observation that deposition of amyloid plaques do not correlate well with neuron loss;<sup id="_ref-Schmitz_0" class="reference"><a href="#_note-Schmitz" title="">[18]</a></sup> however, a majority of researchers support the alternative hypothesis that amyloid is the primary causative agent.<sup id="_ref-Mudher_1" class="reference"><a href="#_note-Mudher" title="">[17]</a></sup></p>
<p>The amyloid hypothesis is initially compelling because the gene for the amyloid beta precursor APP is located on <a href="../../../c/h/r/Chromosome_21.html" title="Chromosome 21">chromosome 21</a>, and patients with <a href="../../../t/r/i/Trisomy_21.html" title="Trisomy 21">trisomy 21</a> - better known as Down syndrome - who thus have an extra <a href="../../../g/e/n/Gene_dosage.html" title="Gene dosage">gene copy</a> almost universally exhibit AD-like disorders by 40 years of age.<sup id="_ref-Nistor_0" class="reference"><a href="#_note-Nistor" title="">[19]</a></sup><sup id="_ref-Lott_0" class="reference"><a href="#_note-Lott" title="">[20]</a></sup> The traditional formulation of the amyloid hypothesis points to the cytotoxicity of mature aggregated amyloid fibrils, which are believed to be the toxic form of the protein responsible for disrupting the cell's calcium ion homeostasis and thus inducing <a href="../../../a/p/o/Apoptosis.html" title="Apoptosis">apoptosis</a>.<sup id="_ref-Yankner_0" class="reference"><a href="#_note-Yankner" title="">[21]</a></sup> A more recent and widely supported hypothesis suggests that the cytotoxic species is an intermediate misfolded form of amyloid beta, neither a soluble monomer nor a mature aggregated polymer but an <a href="../../../o/l/i/Oligomer.html" title="Oligomer">oligomeric</a> species.<sup id="_ref-Blanchard1_0" class="reference"><a href="#_note-Blanchard1" title="">[22]</a></sup> Relevantly, much early development work on lead compounds has focused on the inhibition of fibrillization,<sup id="_ref-Blanchard2_0" class="reference"><a href="#_note-Blanchard2" title="">[23]</a></sup><sup id="_ref-Porat_0" class="reference"><a href="#_note-Porat" title="">[24]</a></sup><sup id="_ref-Kanapathipillai_0" class="reference"><a href="#_note-Kanapathipillai" title="">[25]</a></sup> but the toxic-oligomer theory would imply that prevention of oligomeric assembly is the more important process<sup id="_ref-Lee_0" class="reference"><a href="#_note-Lee" title="">[26]</a></sup> or that a better target lies upstream, for example in the inhibition of APP processing to amyloid beta.<sup id="_ref-Espeseth_0" class="reference"><a href="#_note-Espeseth" title="">[27]</a></sup></p>
<p>It should be noted further that ApoE4, the major genetic risk factor for AD, leads to excess amyloid build up in the brain before AD symptoms arise. Thus, beta-amyloid deposition precedes clinical AD.<sup id="_ref-8" class="reference"><a href="#_note-8" title="">[28]</a></sup> Another strong support for the amyloid hypothesis, which looks at the beta-amyloid as the common initiating factor for the Alzheimer's disease, is that transgenic mice solely expressing a mutant human APP gene develop first diffuse and then fibrillar beta-amyloid plaques, associated with neuronal and microglial damage.<sup id="_ref-9" class="reference"><a href="#_note-9" title="">[29]</a></sup><sup id="_ref-10" class="reference"><a href="#_note-10" title="">[30]</a></sup><sup id="_ref-11" class="reference"><a href="#_note-11" title="">[31]</a></sup></p>
<p><a name="Genetics" id="Genetics"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Genetics">edit</a>]</span> <span class="mw-headline">Genetics</span></h3>
<p>Rare cases of Alzheimer's are caused by dominant genes that run in families. These cases often have an early age of onset. Mutations in presenilin-1 or presenilin-2 genes have been documented in some families. Mutations of presenilin 1 (PS1) lead to the most aggressive form of <a href="../../../f/a/m/Familial_Alzheimer%27s_disease_1c67.html" title="Familial Alzheimer's disease">familial Alzheimer's disease</a> (FAD).<sup id="_ref-Vetrivel_0" class="reference"><a href="#_note-Vetrivel" title="">[32]</a></sup> Evidence from rodent studies suggests that the FAD mutation of PS1 results in impaired <a href="../../../h/i/p/Hippocampus.html" title="Hippocampus">hippocampal</a>-dependent learning which is correlated with reduced <a href="../../../a/d/u/Adult_Neurogenesis_fb72.html" title="Adult Neurogenesis">adult neurogenesis</a> in the <a href="../../../h/i/p/Hippocampus.html" title="Hippocampus">dentate gyrus</a>.<sup id="_ref-12" class="reference"><a href="#_note-12" title="">[33]</a></sup> Mutations in the APP gene on <a href="../../../c/h/r/Chromosome.html" title="Chromosome">chromosome</a> 21 can also cause early onset disease. The presenilins have been identified as essential components of the proteolytic processing machinery that produces beta amyloid peptides through cleavage of APP.</p>
<p>Most cases identified are "sporadic" with no clear family history. Environmental factors sometimes claimed to increase risk of Alzheimer's include prior head injury,<sup id="_ref-Jellinger_0" class="reference"><a href="#_note-Jellinger" title="">[34]</a></sup> particularly repeated trauma,<sup id="_ref-Guskiewicz_0" class="reference"><a href="#_note-Guskiewicz" title="">[35]</a></sup> previous incidents of <a href="../../../m/i/g/Migraine.html" title="Migraine">migraine</a> headaches,<sup id="_ref-Tyas_0" class="reference"><a href="#_note-Tyas" title="">[36]</a></sup> exposure to <a href="../../../d/e/f/Defoliant.html" title="Defoliant">defoliants</a>,<sup id="_ref-Tyas_1" class="reference"><a href="#_note-Tyas" title="">[36]</a></sup> and low activity levels during adulthood.<sup id="_ref-Munoz_0" class="reference"><a href="#_note-Munoz" title="">[37]</a></sup> However, with the exception of previous concussion, none of these environmental risk factors are widely accepted.</p>
<p>Inheritance of the ε4 allele of the ApoE gene is regarded as a risk factor for development of disease, but large-scale genetic association studies raise the possibility that even this does not indicate susceptibility so much as how early one is likely to develop Alzheimer's. There is speculation among genetic experts that there are other risk and protective factor genes that may influence the development of late onset Alzheimer's disease (LOAD). Researchers are investigating the possibility that the regulatory regions of various Alzheimer's associated genes could be important in sporadic Alzheimer's, especially inflammatory activation of these genes. These hypotheses include the amyloid-β precursor protein (APP),<sup id="_ref-13" class="reference"><a href="#_note-13" title="">[38]</a></sup> the beta secretase enzymes<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[39]</a></sup> insulin-degrading enzyme<sup id="_ref-15" class="reference"><a href="#_note-15" title="">[40]</a></sup> endothelin-converting enzymes<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[41]</a></sup> and inflammatory 5-lipoxygenase gene.<sup id="_ref-17" class="reference"><a href="#_note-17" title="">[42]</a></sup></p>
<p><a name="Genetic_linkage" id="Genetic_linkage"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Genetic linkage">edit</a>]</span> <span class="mw-headline">Genetic linkage</span></h3>
<p>Alzheimer's disease is definitely linked to the 1st, 14th,<sup id="_ref-18" class="reference"><a href="#_note-18" title="">[43]</a></sup> and 21st chromosomes, but other linkages are controversial and not, as yet, confirmed. While some genes predisposing to AD have been identified , such as <a href="../../../a/p/o/Apolipoprotein_E_69c9.html" title="Apolipoprotein E">ApoE4</a> on chromosome 19, sporadic AD also involves other risk and protective genes still awaiting confirmation.</p>
<p><a name="Epidemiology_and_prevention" id="Epidemiology_and_prevention"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Epidemiology and prevention">edit</a>]</span> <span class="mw-headline">Epidemiology and prevention</span></h2>
<p>Alzheimer's disease is the most frequent type of dementia in the elderly and affects almost half of all patients with dementia. Correspondingly, advancing age is the primary risk factor for Alzheimer's. Among people aged 65, 2-3% show signs of the disease, while 25–50% of people aged 85 have symptoms of Alzheimer's and an even greater number have some of the pathological hallmarks of the disease without the characteristic symptoms. Every five years after the age of 65, the probability of having the disease doubles.<sup id="_ref-19" class="reference"><a href="#_note-19" title="">[44]</a></sup> The share of Alzheimer's patients over the age of 85 is the fastest growing segment of the Alzheimer's disease population in the US, although current estimates suggest the 75-84 population has about the same number of patients as the over 85 population.<sup id="_ref-20" class="reference"><a href="#_note-20" title="">[45]</a></sup></p>
<p>The evidence relating certain behaviors, dietary intakes, environmental exposures, and diseases to the likelihood of developing Alzhemier's varies in quality and its acceptance by the medical community.<sup id="_ref-21" class="reference"><a href="#_note-21" title="">[46]</a></sup> It is important to understand that interventions that reduce the risk of developing disease in the first place may not alter disease progression after symptoms become apparent. Due to their observational <a href="../../../s/t/u/Study_design.html" title="Study design">design</a>, studies examining disease risk factors are often at risk from <a href="../../../c/o/n/Confounding.html" title="Confounding">confounding</a> variables. Several recent large, <a href="../../../r/a/n/Randomized_controlled_trial.html" title="Randomized controlled trial">randomized controlled trials</a>—in particular the <a href="../../../w/o/m/Women%27s_Health_Initiative_10ab.html" title="Women's Health Initiative">Women's Health Initiative</a>—have called into question preventive measures based on <a href="../../../c/r/o/Cross-sectional_studies.html" title="Cross-sectional studies">cross-sectional studies</a>. Some proposed preventive measures are even based on studies conducted solely in animals.</p>
<p><a name="Risk_reducers" id="Risk_reducers"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Risk reducers">edit</a>]</span> <span class="mw-headline">Risk reducers</span></h3>
<ul>
<li>Intellectual stimulation (e.g., playing <a href="../../../c/h/e/Chess.html" title="Chess">chess</a> or doing <a href="../../../c/r/o/Crosswords.html" title="Crosswords">crosswords</a>)<sup id="_ref-22" class="reference"><a href="#_note-22" title="">[47]</a></sup></li>
<li>Regular physical exercise<sup id="_ref-23" class="reference"><a href="#_note-23" title="">[48]</a></sup></li>
<li>Regular social interaction <a href="http://news.bbc.co.uk/2/hi/health/6332883.stm" class="external autonumber" title="http://news.bbc.co.uk/2/hi/health/6332883.stm" rel="nofollow">[9]</a></li>
<li>A <a href="../../../m/e/d/Mediterranean_diet.html" title="Mediterranean diet">Mediterranean diet</a> with fruits and vegetables and low in saturated fat,<sup id="_ref-24" class="reference"><a href="#_note-24" title="">[49]</a></sup> supplemented in particular with:
<ul>
<li><a href="../../../b/_/v/B_vitamins.html" title="B vitamins">B vitamins</a><sup id="_ref-25" class="reference"><a href="#_note-25" title="">[50]</a></sup></li>
<li><a href="../../../o/m/e/Omega-3_fatty_acids.html" title="Omega-3 fatty acids">Omega-3 fatty acids</a>, especially <a href="../../../d/o/c/Docosahexaenoic_acid.html" title="Docosahexaenoic acid">Docosahexaenoic acid</a><sup id="_ref-26" class="reference"><a href="#_note-26" title="">[51]</a></sup><sup id="_ref-27" class="reference"><a href="#_note-27" title="">[52]</a></sup></li>
<li>Fruit and vegetable juice<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[53]</a></sup><sup id="_ref-29" class="reference"><a href="#_note-29" title="">[54]</a></sup></li>
<li>High doses of the <a href="../../../a/n/t/Antioxidant.html" title="Antioxidant">antioxidant</a> <a href="../../../v/i/t/Vitamin_E_df8b.html" title="Vitamin E">Vitamin E</a> (in combination with <a href="../../../v/i/t/Vitamin_C_bba2.html" title="Vitamin C">vitamin C</a>) seem to reduce Alzheimer's risk in cross sectional studies but not in a randomized trial and so are not currently a recommended <a href="../../../p/r/e/Preventative_medicine.html" title="Preventative medicine">preventive measure</a> because of observed increases in overall mortality<sup id="_ref-30" class="reference"><a href="#_note-30" title="">[55]</a></sup><sup id="_ref-31" class="reference"><a href="#_note-31" title="">[56]</a></sup></li>
</ul>
</li>
<li><a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">Cholesterol</a>-lowering drugs (<a href="../../../s/t/a/Statins.html" title="Statins">statins</a>) reduce Alzheimer's risk in observational studies but so far not in randomized controlled trials<sup id="_ref-32" class="reference"><a href="#_note-32" title="">[57]</a></sup></li>
<li>Female <a href="../../../h/o/r/Hormone_replacement_therapy.html" title="Hormone replacement therapy">Hormone replacement therapy</a> is no longer thought to prevent dementia based on data from the <a href="../../../w/o/m/Women%27s_Health_Initiative_10ab.html" title="Women's Health Initiative">Women's Health Initiative</a></li>
<li>Long-term usage of non-steroidal anti-inflammatory drugs (NSAIDs), used to reduce joint inflammation and pain, are associated with a reduced likelihood of developing AD, according to some observational studies.<sup id="_ref-33" class="reference"><a href="#_note-33" title="">[58]</a></sup><sup id="_ref-34" class="reference"><a href="#_note-34" title="">[59]</a></sup> The risks appear to outweigh the drugs' benefit as a method of <a href="../../../p/r/i/Primary_prevention.html" title="Primary prevention">primary prevention</a>.<sup id="_ref-2006AAGP_0" class="reference"><a href="#_note-2006AAGP" title="">[60]</a></sup></li>
</ul>
<ul>
<li>One recent research study has found that <a href="../../../c/a/n/Cannabinoids.html" title="Cannabinoids">cannabinoids</a>, the psychoactive compounds in <a href="../../../m/a/r/Marijuana.html" title="Marijuana">marijuana</a>, "succeed in preventing the neurodegenerative process occurring in the disease."<sup id="_ref-35" class="reference"><a href="#_note-35" title="">[61]</a></sup>However, this finding has not been replicated.</li>
</ul>
<p><a name="Risk_factors" id="Risk_factors"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Risk factors">edit</a>]</span> <span class="mw-headline">Risk factors</span></h3>
<ul>
<li>Advancing age</li>
<li>Reduced testosterone levels.<sup id="_ref-36" class="reference"><a href="#_note-36" title="">[62]</a></sup></li>
<li>ApoE epsilon 4 genotype (in some populations)<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li><a href="../../../h/e/a/Head_injury.html" title="Head injury">Head injury</a><sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Poor cardiovascular health (including <a href="../../../t/o/b/Tobacco_smoking.html" title="Tobacco smoking">smoking</a>, <a href="../../../d/i/a/Diabetes.html" title="Diabetes">diabetes</a>, <a href="../../../h/y/p/Hypertension.html" title="Hypertension">hypertension</a>, <a href="../../../h/i/g/High_cholesterol.html" title="High cholesterol">high cholesterol</a>)<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
<li>Exposure to light metals in particular <a href="../../../a/l/u/Aluminum.html" title="Aluminum">Aluminum</a> is a proposed but not widely-accepted risk factor.<sup id="_ref-37" class="reference"><a href="#_note-37" title="">[63]</a></sup><sup id="_ref-38" class="reference"><a href="#_note-38" title="">[64]</a></sup> <a href="../../../a/l/u/Aluminium.html" title="Aluminium">Aluminium</a>, a neurotoxin, is often present in higher quantities in brains of Alzheimers patients, and the relationship between aluminum and Alzheimers is disputed by scientists.<sup id="_ref-39" class="reference"><a href="#_note-39" title="">[65]</a></sup></li>
</ul>
<p>In one set of studies aluminum absorption is 2-3-fold higher in Alzheimer's patients as compared to aged-matched controls and 6-fold higher in Down's syndrome, a condition having the pathologic hallmarks of AD.(2,3) In addition, it has been shown that a number of organic acids, such as lactic, gluconic, malic, citric and oxalic acids, significantly increase aluminum absorption and deposition in the brain.<sup id="_ref-40" class="reference"><a href="#_note-40" title="">[66]</a></sup> However, the disease process itself may have weaked the barrier to absorption of aluminum.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>There is currently no cure for Alzheimer's disease. Currently available medications offer relatively small symptomatic benefit for some patients but do not slow disease progression. The American Association for Geriatric Psychiatry published a consensus statement on Alzheimer's treatment in 2006.<sup id="_ref-2006AAGP_1" class="reference"><a href="#_note-2006AAGP" title="">[60]</a></sup></p>
<p><a name="Acetylcholinesterase_inhibitors" id="Acetylcholinesterase_inhibitors"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Acetylcholinesterase inhibitors">edit</a>]</span> <span class="mw-headline">Acetylcholinesterase inhibitors</span></h3>
<p><a href="../../../a/c/e/Acetylcholinesterase.html" title="Acetylcholinesterase">Acetylcholinesterase</a> (AChE) inhibition was thought to be important because there is a reduction in activity of the <a href="../../../c/h/o/Cholinergic.html" title="Cholinergic">cholinergic</a> neurons. AChE-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons). Acetylcholinesterase-inhibitors seemed to modestly moderate symptoms but do not alter the course of the underlying dementing process.<sup id="_ref-41" class="reference"><a href="#_note-41" title="">[67]</a></sup><sup id="_ref-42" class="reference"><a href="#_note-42" title="">[68]</a></sup><sup id="_ref-43" class="reference"><a href="#_note-43" title="">[69]</a></sup></p>
<p>Examples include:</p>
<ul>
<li><a href="../../../t/a/c/Tacrine.html" title="Tacrine">tacrine</a> - no longer clinically used</li>
<li><a href="../../../d/o/n/Donepezil.html" title="Donepezil">donepezil</a> - (marketed as Aricept)</li>
<li><a href="../../../g/a/l/Galantamine.html" title="Galantamine">galantamine</a> - (marketed as Razadyne in the U.S.A. Marketed as Reminyl or Nivalin in the rest of the world)</li>
<li><a href="../../../r/i/v/Rivastigmine.html" title="Rivastigmine">rivastigmine</a> - (marketed as Exelon)</li>
</ul>
<p>There is significant doubt as to the effectiveness of cholinesterase inhibitors. A number of recent articles have criticized the design of studies reporting benefit from these drugs, concluding that they have doubtful clinical utility, are costly, and confer many side effects.<sup id="_ref-44" class="reference"><a href="#_note-44" title="">[70]</a></sup><sup id="_ref-45" class="reference"><a href="#_note-45" title="">[71]</a></sup> The pharmaceutical companies, but also some independent clinicians, dispute the conclusions of these articles. A <a href="../../../t/r/a/Transdermal_patch.html" title="Transdermal patch">transdermal patch</a> is under development that may ease administration of rivastigmine.<sup id="_ref-46" class="reference"><a href="#_note-46" title="">[72]</a></sup></p>
<p><a name="Gingko_biloba" id="Gingko_biloba"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Gingko biloba">edit</a>]</span> <span class="mw-headline">Gingko biloba</span></h3>
<p>One of the natural extracts that has been examined in Alzheimer's is <a href="../../../g/i/n/Ginkgo.html" title="Ginkgo">Ginkgo</a> (<i>Ginkgo biloba</i>), also known as the Maidenhair Tree. The extract of the Ginkgo leaves contains flavonoid glycosides and terpenoids, and both seeds and leaves have been used pharmaceutically in China and the West. Examining over 50 studies conducted on Ginkgo for the treatment of "cognitive impairment and dementia," a Cochrane Review concludes that "there is promising evidence of improvement in cognition and function associated with Ginkgo." According to this review the two randomized controlled studies that focused on Alzheimer's patients both showed significant improvement in these areas. The review calls for a large study which can "provide robust estimates of the size and mechanism of any treatment effects."<sup id="_ref-alzheim_0" class="reference"><a href="#_note-alzheim" title="">[73]</a></sup> The AAGP review<sup id="_ref-2006AAGP_2" class="reference"><a href="#_note-2006AAGP" title="">[60]</a></sup> did not recommend Ginkgo neither did it warn against its use. A large, randomized clinical study in the US called the GEM study is underway (fully enrolled) and examining the effect of Ginkgo to prevent dementia.<sup id="_ref-47" class="reference"><a href="#_note-47" title="">[74]</a></sup></p>
<p><a name="NMDA_antagonists" id="NMDA_antagonists"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: NMDA antagonists">edit</a>]</span> <span class="mw-headline">NMDA antagonists</span></h3>
<p>Recent evidence of the involvement of <a href="../../../g/l/u/Glutamate.html" title="Glutamate">glutamatergic</a> neuronal <a href="../../../e/x/c/Excitotoxicity.html" title="Excitotoxicity">excitotoxicity</a> causes Alzheimer's disease led to the development and introduction of <a href="../../../m/e/m/Memantine.html" title="Memantine">memantine</a>. Memantine is a novel <a href="../../../n/m/d/NMDA_receptor_caab.html" title="NMDA receptor">NMDA receptor</a> <a href="../../../r/e/c/Receptor_antagonist.html" title="Receptor antagonist">antagonist</a>, and has been shown to be moderately clinically efficacious.<sup id="_ref-Areosa_0" class="reference"><a href="#_note-Areosa" title="">[75]</a></sup> Memantine is marketed as Akatinol, Axura, Ebixa and Namenda.</p>
<p><a name="Psychosocial_interventions" id="Psychosocial_interventions"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Psychosocial interventions">edit</a>]</span> <span class="mw-headline">Psychosocial interventions</span></h3>
<p>Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatment, especially in the early to moderately advanced stages of disease. Treatment modalities include counseling, psychotherapy (if cognitive functioning is adequate), reminiscent therapy, reality orientation therapy, and behavioral reinforcements as well as cognitive rehabilitation training.<sup id="_ref-48" class="reference"><a href="#_note-48" title="">[76]</a></sup><sup id="_ref-49" class="reference"><a href="#_note-49" title="">[77]</a></sup></p>
<p><a name="Treatments_in_clinical_development" id="Treatments_in_clinical_development"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Treatments in clinical development">edit</a>]</span> <span class="mw-headline">Treatments in clinical development</span></h3>
<p>A large number of potential treatments for Alzheimer's disease are currently under investigation, including four compounds being studied in <a href="../../../r/e/g/Regulatory_requirement.html" title="Regulatory requirement">phase 3</a> clinical trials. Xaliproden had been shown to reduce neurodegeneration in animal studies.<sup id="_ref-50" class="reference"><a href="#_note-50" title="">[78]</a></sup> Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques. <a href="../../../r/-/f/R-flurbiprofen.html" title="R-flurbiprofen">R-flurbiprofen</a> (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.<sup id="_ref-51" class="reference"><a href="#_note-51" title="">[79]</a></sup><sup id="_ref-52" class="reference"><a href="#_note-52" title="">[80]</a></sup> <a href="../../../l/e/u/Leuprolide.html" title="Leuprolide">Leuprolide</a> is has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.<sup id="_ref-53" class="reference"><a href="#_note-53" title="">[81]</a></sup></p>
<ul>
<li><b>Vaccines</b> or <a href="../../../i/m/m/Immunotherapy.html" title="Immunotherapy">immunotherapy</a> for Alzheimer's, unlike typical <a href="../../../v/a/c/Vaccines.html" title="Vaccines">vaccines</a>, would be used to treat diagnosed patients rather than for disease prevention. Ongoing efforts are based on the idea that, by training the immune system to recognize and attack beta-amyloid, the immune system might reverse deposition of amyloid and thus stop the disease. Initial results using this approach in animals were promising, and human-trials of drug AN-1792 showed results in 20% of patients; however, 6% of multi-dosed participants (18 of 300) developed <a href="../../../e/n/c/Encephalitis.html" title="Encephalitis">encephalitis</a> in 2002, and the trials were stopped. Participants in the halted trials continued to be followed, and 20% "developed high levels of antibodies to beta-amyloid" and some showed slower progression of the disease, maintaining memory-test levels while placebo-patients worsened.<sup id="_ref-54" class="reference"><a href="#_note-54" title="">[82]</a></sup> Work is continuing on less toxic <a href="../../../a/m/y/Amyloid_beta.html" title="Amyloid beta">Aβ</a> vaccines, such as a <a href="../../../d/n/a/DNA_396c.html" title="DNA">DNA</a>-based therapy that recently showed promise in mice. Researchers from University of South Florida announced a patch version of the drug was shown to be safe and effective when tested on mice.<sup id="_ref-55" class="reference"><a href="#_note-55" title="">[83]</a></sup></li>
</ul>
<ul>
<li><b>Proposed alternative treatments</b> for Alzheimer's include a range of herbal compounds and <a href="../../../d/i/e/Dietary_supplements.html" title="Dietary supplements">dietary supplements</a>. In the AAGP review from 2006,<sup id="_ref-2006AAGP_3" class="reference"><a href="#_note-2006AAGP" title="">[60]</a></sup><a href="../../../t/o/c/Tocopherol.html" title="Tocopherol">Vitamin E</a> in doses below 400 IU was mentioned as having conflicting evidence in efficacy to prevent AD. Higher doses were discouraged as these may be linked with higher mortality related to cardiac events.</li>
</ul>
<p>Laboratory studies with cells and animals continually fuel the pipeline of potential treatments. Some currently approved drugs such as <a href="../../../s/t/a/Statin.html" title="Statin">statins</a> and <a href="../../../t/h/i/Thiazolidinedione.html" title="Thiazolidinedione">thiazolidinediones</a><sup id="_ref-56" class="reference"><a href="#_note-56" title="">[84]</a></sup> have also been under investigation for the treatment and prevention of Alzheimer’s. Recent <a href="../../../c/l/i/Clinical_trial.html" title="Clinical trial">clinical trials</a> for Phase 2 and Phase 3 in this category have taken 12 to 18 months under study drug, plus additional months for patient enrollment and analysis. Compounds that are just entering into human trials or are in pre-clinical trials would be at least 4 years from being available to the public and would be available only if they can demonstrate safety and efficacy in human trials.</p>
<p><a name="Occupational_and_lifestyle_therapies" id="Occupational_and_lifestyle_therapies"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Occupational and lifestyle therapies">edit</a>]</span> <span class="mw-headline">Occupational and lifestyle therapies</span></h3>
<p>Modifications to the living environment and lifestyle of the Alzheimer's patient can improve functional performance and ease caretaker burden. Assessment by an <a href="../../../o/c/c/Occupational_therapist.html" title="Occupational therapist">occupational therapist</a> is often indicated. Adherence to simplified routines and labeling of household items to cue the patient can aid with <a href="../../../a/c/t/Activities_of_daily_living.html" title="Activities of daily living">activities of daily living</a>, while placing safety locks on cabinets, doors, and gates and securing hazardous chemicals and guns can prevent accidents and wandering. Changes in routine or environment can trigger or exacerbate agitiation, whereas well-lit rooms, adquate rest, and avoidance of excess stimulation all help prevent such episodes.<sup id="_ref-57" class="reference"><a href="#_note-57" title="">[85]</a></sup> Appropriate social and visual stimulation, however, can improve function by increasing awareness and orientation. For instance, boldly colored tableware aids those with severe AD, helping people overcome a diminished sensitivity to visual contrast to increase food and beverage intake.<sup id="_ref-58" class="reference"><a href="#_note-58" title="">[86]</a></sup></p>
<p><a name="Social_issues" id="Social_issues"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Social issues">edit</a>]</span> <span class="mw-headline">Social issues</span></h2>
<p>Alzheimer's is a major public health challenge since the median age of the industrialized world's population is increasing gradually.<sup id="_ref-59" class="reference"><a href="#_note-59" title="">[87]</a></sup> Indeed, much of the concern about the solvency of governmental social safety nets is founded on estimates of the costs of caring for <a href="../../../b/a/b/Baby_boomers.html" title="Baby boomers">baby boomers</a>, assuming that they develop Alzheimer's in the same proportions as earlier generations. For this reason, money spent informing the public of available effective prevention methods may yield disproportionate benefits.</p>
<p>The role of family <a href="../../../c/a/r/Caregiver.html" title="Caregiver">caregivers</a> has also become more prominent, as care in the familiar surroundings of home may delay onset of some symptoms and delay or eliminate the need for more professional and costly levels of care. However, home-based care may entail tremendous economic, emotional, and even psychological costs as well (see <a href="../../../e/l/d/Elderly_care.html" title="Elderly care">elderly care</a>). Family caregivers often give up time from work and foregoing pay to spend 47 hours per week on average with an affected loved one who frequently cannot be left alone. From a survey of patients with long term care insurance, direct and indirect costs of caring for an Alzheimer's patient average $77,500 per year.<sup id="_ref-60" class="reference"><a href="#_note-60" title="">[88]</a></sup></p>
<p><a name="Statistics_on_Alzheimer.27s_disease" id="Statistics_on_Alzheimer.27s_disease"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Statistics on Alzheimer's disease">edit</a>]</span> <span class="mw-headline">Statistics on Alzheimer's disease</span></h2>
<ul>
<li>In the United States of America, AD was the 7th leading cause of death in 2004, with 65,829 number of deaths (and rising).<sup id="_ref-61" class="reference"><a href="#_note-61" title="">[89]</a></sup></li>
<li>At over $100 billion per year, AD is the third most costly disease in the U.S., after heart disease and cancer.<sup id="_ref-62" class="reference"><a href="#_note-62" title="">[90]</a></sup></li>
<li>There are an estimated 24 million people with dementia worldwide.<sup id="_ref-63" class="reference"><a href="#_note-63" title="">[91]</a></sup> More than 5 million Americans are estimated to have Alzheimer’s disease.<sup id="_ref-AboutAD_0" class="reference"><a href="#_note-AboutAD" title="">[92]</a></sup></li>
<li>By 2040, it is projected that this figure will have increased to 81 million.</li>
<li>It is projected that 14.3 million Americans will have the disease by mid-century: a 350 percent increase from 2000.<sup id="_ref-64" class="reference"><a href="#_note-64" title="">[93]</a></sup></li>
<li>The federal government estimates spending approximately $647 million for Alzheimer’s disease research in fiscal year 2005.<sup id="_ref-AboutAD_1" class="reference"><a href="#_note-AboutAD" title="">[92]</a></sup></li>
<li>The average lifetime cost of care for an individual with Alzheimer’s is $174,000.<sup class="noprint"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></li>
</ul>
<p><a name="Notable_cases" id="Notable_cases"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: Notable cases">edit</a>]</span> <span class="mw-headline">Notable cases</span></h2>
<p><a href="../../../l/i/s/List_of_famous_Alzheimer%27s_disease_sufferers_6714.html" title="List of famous Alzheimer's disease sufferers">Notable cases</a> of Alzheimer's disease have included President <a href="../../../r/o/n/Ronald_Reagan_9da1.html" title="Ronald Reagan">Ronald Reagan</a>, <a href="../../../c/h/a/Charlton_Heston_4d26.html" title="Charlton Heston">Charlton Heston</a>, <a href="../../../f/e/r/Ferenc_Puskas_f3e7.html" title="Ferenc Puskas">Ferenc Puskas</a> and <a href="../../../r/i/t/Rita_Hayworth_abca.html" title="Rita Hayworth">Rita Hayworth</a>.<sup id="_ref-65" class="reference"><a href="#_note-65" title="">[94]</a></sup> For a more comprehensive list, see <a href="../../../l/i/s/List_of_famous_people_with_Alzheimer%27s_disease_3e7e.html" title="List of famous people with Alzheimer's disease">List of famous people with Alzheimer's disease</a>.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li>Other major <a href="../../../n/e/u/Neurodegenerative_disease.html" title="Neurodegenerative disease">neurodegenerative diseases</a> including <a href="../../../p/a/r/Parkinson%27s_disease.html" title="Parkinson's disease">Parkinson's disease</a>, <a href="../../../h/u/n/Huntington%27s_disease.html" title="Huntington's disease">Huntington's disease</a>, and <a href="../../../a/m/y/Amyotrophic_lateral_sclerosis.html" title="Amyotrophic lateral sclerosis">amyotrophic lateral sclerosis</a></li>
<li>Diseases included in the <a href="../../../d/i/f/Differential_diagnosis.html" title="Differential diagnosis">differential diagnosis</a> of Alzheimer's, including <a href="../../../d/e/m/Dementia_with_Lewy_bodies_9ef1.html" title="Dementia with Lewy bodies">dementia with Lewy bodies</a>, <a href="../../../f/r/o/Frontotemporal_dementia.html" title="Frontotemporal dementia">frontotemporal dementia</a>, <a href="../../../f/a/m/Familial_Alzheimer_disease_8838.html" title="Familial Alzheimer disease">familial Alzheimer disease</a>, and <a href="../../../m/u/l/Multi-infarct_dementia.html" title="Multi-infarct dementia">multi-infarct dementia</a></li>
<li>Information on the molecular pathogenesis of Alzheimer's disease, including <a href="../../../a/m/y/Amyloid_beta.html" title="Amyloid beta">amyloid beta</a>, <a href="../../../b/e/t/Beta-secretase.html" title="Beta-secretase">beta-secretase</a>, and <a href="../../../t/a/u/Tau_protein.html" title="Tau protein">tau protein</a></li>
<li>Articles related to <a href="../../../m/e/m/Memory.html" title="Memory">memory</a>, including <a href="../../../m/e/m/Memory_and_aging.html" title="Memory and aging">memory and aging</a>, <a href="../../../d/e/m/Dementia.html" title="Dementia">dementia</a>, and <a href="../../../a/m/n/Amnesia.html" title="Amnesia">amnesia</a></li>
<li><a href="../../../q/p/n/QPNC-PAGE_2436.html" title="QPNC-PAGE">New approach</a> concerning the diagnosis and therapy of protein-misfolding diseases</li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <a href="http://www.nytimes.com/2007/01/15/health/15newgene.html?em&amp;ex=1168923600&amp;en=a1433238cffd4800&amp;ei=5087%0A" class="external text" title="http://www.nytimes.com/2007/01/15/health/15newgene.html?em&amp;ex=1168923600&amp;en=a1433238cffd4800&amp;ei=5087%0A" rel="nofollow">"Study Detects a Gene Linked to Alzheimer’s"</a>. N. Wade, New York Times, <a href="../../../j/a/n/January_15.html" title="January 15">January 15</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite class="book" style="font-style:normal">Maurer, Konrad; Maurer, Ulrike (2003). <i>Alzheimer: the life of a physician and the career of a disease</i>. New York: Columbia University Press. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-231-11896-1</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Alzheimer%3A+the+life+of+a+physician+and+the+career+of+a+disease&amp;rft.title=Alzheimer%3A+the+life+of+a+physician+and+the+career+of+a+disease&amp;rft.aulast=Maurer&amp;rft.aufirst=Konrad&amp;rft.date=2003&amp;rft.pub=Columbia+University+Press&amp;rft.place=New+York">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <a href="http://www.nature.com/ncpneuro/journal/v3/n2/full/ncpneuro0402.html" class="external text" title="http://www.nature.com/ncpneuro/journal/v3/n2/full/ncpneuro0402.html" rel="nofollow">"The current status of mild cognitive impairment�what do we tell our patients?"</a>. Ronald C Petersen, Nature Clinical Practice Neurology (2007) 3, 60-61.</li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Dougall N, Bruggink S, Ebmeier K. "Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia.". <i>Am J Geriatr Psychiatry</i> <b>12</b> (6): 554-70. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15545324" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15545324">PMID 15545324</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Systematic+review+of+the+diagnostic+accuracy+of+99mTc-HMPAO-SPECT+in+dementia.&amp;rft.title=Am+J+Geriatr+Psychiatry&amp;rft.jtitle=Am+J+Geriatr+Psychiatry&amp;rft.volume=12&amp;rft.issue=6&amp;rft.au=Dougall+N%2C+Bruggink+S%2C+Ebmeier+K&amp;rft.pages=554-70">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite style="font-style:normal">Bonte F, Harris T, Hynan L, Bigio E, White C (2006). "Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation.". <i>Clin Nucl Med</i> <b>31</b> (7): 376-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16785801" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16785801">PMID 16785801</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Tc-99m+HMPAO+SPECT+in+the+differential+diagnosis+of+the+dementias+with+histopathologic+confirmation.&amp;rft.title=Clin+Nucl+Med&amp;rft.jtitle=Clin+Nucl+Med&amp;rft.date=2006&amp;rft.volume=31&amp;rft.issue=7&amp;rft.au=Bonte+F%2C+Harris+T%2C+Hynan+L%2C+Bigio+E%2C+White+C&amp;rft.pages=376-8">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> Cervilla et al (2004). <a href="http://www.jnnp.com/cgi/content/abstract/75/8/1100" class="external text" title="http://www.jnnp.com/cgi/content/abstract/75/8/1100" rel="nofollow">Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype</a>. Psychiatry 2004;75:1100-1106.. Retrieved on <a href="../../../a/u/g/August_6.html" title="August 6">August 6</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> Dorene Rentz, Brigham and Women's Hospital's Department of Neurology and Harvard Medical School. <a href="http://laboratory-manager.advanceweb.com/common/editorial/editorial.aspx?CC=27318" class="external text" title="http://laboratory-manager.advanceweb.com/common/editorial/editorial.aspx?CC=27318" rel="nofollow">More Sensitive Test Norms Better Predict Who Might Develop Alzheimer's Disease</a>. Neuropsychology, published by the American Psychological Association. Retrieved on <a href="../../../a/u/g/August_6.html" title="August 6">August 6</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>.</li>
<li id="_note-Hashimoto"><b><a href="#_ref-Hashimoto_0" title="">^</a></b> <cite style="font-style:normal">Hashimoto M, Rockenstein E, Crews L, Masliah E (2003). "Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.". <i>Neuromolecular Med</i> <b>4</b> (1-2): 21-36. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14528050" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14528050">PMID 14528050</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Role+of+protein+aggregation+in+mitochondrial+dysfunction+and+neurodegeneration+in+Alzheimer%27s+and+Parkinson%27s+diseases.&amp;rft.title=Neuromolecular+Med&amp;rft.jtitle=Neuromolecular+Med&amp;rft.date=2003&amp;rft.volume=4&amp;rft.issue=1-2&amp;rft.au=Hashimoto+M%2C+Rockenstein+E%2C+Crews+L%2C+Masliah+E&amp;rft.pages=21-36">&#160;</span></li>
<li id="_note-Kerr"><b><a href="#_ref-Kerr_0" title="">^</a></b> <cite style="font-style:normal">Kerr M, Small D (2005). "Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.". <i>J Neurosci Res</i> <b>80</b> (2): 151-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15672415" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15672415">PMID 15672415</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Cytoplasmic+domain+of+the+beta-amyloid+protein+precursor+of+Alzheimer%27s+disease%3A+function%2C+regulation+of+proteolysis%2C+and+implications+for+drug+development.&amp;rft.title=J+Neurosci+Res&amp;rft.jtitle=J+Neurosci+Res&amp;rft.date=2005&amp;rft.volume=80&amp;rft.issue=2&amp;rft.au=Kerr+M%2C+Small+D&amp;rft.pages=151-9">&#160;</span></li>
<li id="_note-Cai"><b><a href="#_ref-Cai_0" title="">^</a></b> <cite style="font-style:normal">Cai D, Netzer W, Zhong M, Lin Y, Du G, Frohman M, Foster D, Sisodia S, Xu H, Gorelick F, Greengard P (2006). "Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation.". <i>Proc Natl Acad Sci U S A</i> <b>103</b> (6): 1941-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16449386" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16449386">PMID 16449386</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Presenilin-1+uses+phospholipase+D1+as+a+negative+regulator+of+beta-amyloid+formation.&amp;rft.title=Proc+Natl+Acad+Sci+U+S+A&amp;rft.jtitle=Proc+Natl+Acad+Sci+U+S+A&amp;rft.date=2006&amp;rft.volume=103&amp;rft.issue=6&amp;rft.au=Cai+D%2C+Netzer+W%2C+Zhong+M%2C+Lin+Y%2C+Du+G%2C+Frohman+M%2C+Foster+D%2C+Sisodia+S%2C+Xu+H%2C+Gorelick+F%2C+Greengard+P&amp;rft.pages=1941-6">&#160;</span></li>
<li id="_note-Ohnishi"><b><a href="#_ref-Ohnishi_0" title="">^</a></b> <cite style="font-style:normal">Ohnishi S, Takano K (2004). "Amyloid fibrils from the viewpoint of protein folding.". <i>Cell Mol Life Sci</i> <b>61</b> (5): 511-24. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15004691" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15004691">PMID 15004691</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Amyloid+fibrils+from+the+viewpoint+of+protein+folding.&amp;rft.title=Cell+Mol+Life+Sci&amp;rft.jtitle=Cell+Mol+Life+Sci&amp;rft.date=2004&amp;rft.volume=61&amp;rft.issue=5&amp;rft.au=Ohnishi+S%2C+Takano+K&amp;rft.pages=511-24">&#160;</span></li>
<li id="_note-Goedert"><b><a href="#_ref-Goedert_0" title="">^</a></b> <cite style="font-style:normal">Goedert M, Klug A, Crowther R (2006). "Tau protein, the paired helical filament and Alzheimer's disease.". <i>J Alzheimers Dis</i> <b>9</b> (3 Suppl): 195-207. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16914859" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16914859">PMID 16914859</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Tau+protein%2C+the+paired+helical+filament+and+Alzheimer%27s+disease.&amp;rft.title=J+Alzheimers+Dis&amp;rft.jtitle=J+Alzheimers+Dis&amp;rft.date=2006&amp;rft.volume=9&amp;rft.issue=3+Suppl&amp;rft.au=Goedert+M%2C+Klug+A%2C+Crowther+R&amp;rft.pages=195-207">&#160;</span></li>
<li id="_note-Tiraboschi"><b><a href="#_ref-Tiraboschi_0" title="">^</a></b> <cite style="font-style:normal">Tiraboschi P, Hansen L, Thal L, Corey-Bloom J (2004). "The importance of neuritic plaques and tangles to the development and evolution of AD.". <i>Neurology</i> <b>62</b> (11): 1984-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15184601" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15184601">PMID 15184601</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+importance+of+neuritic+plaques+and+tangles+to+the+development+and+evolution+of+AD.&amp;rft.title=Neurology&amp;rft.jtitle=Neurology&amp;rft.date=2004&amp;rft.volume=62&amp;rft.issue=11&amp;rft.au=Tiraboschi+P%2C+Hansen+L%2C+Thal+L%2C+Corey-Bloom+J&amp;rft.pages=1984-9">&#160;</span></li>
<li id="_note-Wenk">^ <a href="#_ref-Wenk_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Wenk_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Wenk G. "Neuropathologic changes in Alzheimer's disease.". <i>J Clin Psychiatry</i> <b>64 Suppl 9</b>: 7-10. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12934968" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12934968">PMID 12934968</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Neuropathologic+changes+in+Alzheimer%27s+disease.&amp;rft.title=J+Clin+Psychiatry&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.volume=64+Suppl+9&amp;rft.au=Wenk+G&amp;rft.pages=7-10">&#160;</span></li>
<li id="_note-7"><b><a href="#_ref-7" title="">^</a></b> Baskys. <a href="http://www.ucihealth.com/News/Releases/Receptor_found_treat_stroke_alzheimers_9-13-00.htm" class="external text" title="http://www.ucihealth.com/News/Releases/Receptor_found_treat_stroke_alzheimers_9-13-00.htm" rel="nofollow">Receptor found that could lead to better treatments for stroke, alzheimer's disease</a>. UCI Medical Center. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../n/o/v/November_4.html" title="November 4">11-04</a>.</li>
<li id="_note-Shen"><b><a href="#_ref-Shen_0" title="">^</a></b> <cite style="font-style:normal">Shen Z (2004). "Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease.". <i>Med Hypotheses</i> <b>63</b> (2): 308-21. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15236795" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15236795">PMID 15236795</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Brain+cholinesterases%3A+II.+The+molecular+and+cellular+basis+of+Alzheimer%27s+disease.&amp;rft.title=Med+Hypotheses&amp;rft.jtitle=Med+Hypotheses&amp;rft.date=2004&amp;rft.volume=63&amp;rft.issue=2&amp;rft.au=Shen+Z&amp;rft.pages=308-21">&#160;</span></li>
<li id="_note-Mudher">^ <a href="#_ref-Mudher_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Mudher_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Mudher A, Lovestone S (2002). "Alzheimer's disease-do tauists and baptists finally shake hands?". <i>Trends Neurosci</i> <b>25</b> (1): 22-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11801334" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11801334">PMID 11801334</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alzheimer%27s+disease-do+tauists+and+baptists+finally+shake+hands%3F&amp;rft.title=Trends+Neurosci&amp;rft.jtitle=Trends+Neurosci&amp;rft.date=2002&amp;rft.volume=25&amp;rft.issue=1&amp;rft.au=Mudher+A%2C+Lovestone+S&amp;rft.pages=22-6">&#160;</span></li>
<li id="_note-Schmitz"><b><a href="#_ref-Schmitz_0" title="">^</a></b> <cite style="font-style:normal">Schmitz C, Rutten B, Pielen A, Schäfer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch H, Pradier L, Bayer T (2004). "Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.". <i>Am J Pathol</i> <b>164</b> (4): 1495-502. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15039236" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15039236">PMID 15039236</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Hippocampal+neuron+loss+exceeds+amyloid+plaque+load+in+a+transgenic+mouse+model+of+Alzheimer%27s+disease.&amp;rft.title=Am+J+Pathol&amp;rft.jtitle=Am+J+Pathol&amp;rft.date=2004&amp;rft.volume=164&amp;rft.issue=4&amp;rft.au=Schmitz+C%2C+Rutten+B%2C+Pielen+A%2C+Sch%C3%A4fer+S%2C+Wirths+O%2C+Tremp+G%2C+Czech+C%2C+Blanchard+V%2C+Multhaup+G%2C+Rezaie+P%2C+Korr+H%2C+Steinbusch+H%2C+Pradier+L%2C+Bayer+T&amp;rft.pages=1495-502">&#160;</span></li>
<li id="_note-Nistor"><b><a href="#_ref-Nistor_0" title="">^</a></b> <cite style="font-style:normal">Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E (2006). "Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain.". <i>Neurobiol Aging</i> (epub). <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16904243" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16904243">PMID 16904243</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alpha-+and+beta-secretase+activity+as+a+function+of+age+and+beta-amyloid+in+Down+syndrome+and+normal+brain.&amp;rft.title=Neurobiol+Aging&amp;rft.jtitle=Neurobiol+Aging&amp;rft.date=2006&amp;rft.issue=epub&amp;rft.au=Nistor+M%2C+Don+M%2C+Parekh+M%2C+Sarsoza+F%2C+Goodus+M%2C+Lopez+GE%2C+Kawas+C%2C+Leverenz+J%2C+Doran+E%2C+Lott+IT%2C+Hill+M%2C+Head+E">&#160;</span></li>
<li id="_note-Lott"><b><a href="#_ref-Lott_0" title="">^</a></b> <cite style="font-style:normal">Lott I, Head E (2005). "Alzheimer disease and Down syndrome: factors in pathogenesis.". <i>Neurobiol Aging</i> <b>26</b> (3): 383-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15639317" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15639317">PMID 15639317</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alzheimer+disease+and+Down+syndrome%3A+factors+in+pathogenesis.&amp;rft.title=Neurobiol+Aging&amp;rft.jtitle=Neurobiol+Aging&amp;rft.date=2005&amp;rft.volume=26&amp;rft.issue=3&amp;rft.au=Lott+I%2C+Head+E&amp;rft.pages=383-9">&#160;</span></li>
<li id="_note-Yankner"><b><a href="#_ref-Yankner_0" title="">^</a></b> <cite style="font-style:normal">Yankner B, Duffy L, Kirschner D (1990). "Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.". <i>Science</i> <b>250</b> (4978): 279-82. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2218531" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2218531">PMID 2218531</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Neurotrophic+and+neurotoxic+effects+of+amyloid+beta+protein%3A+reversal+by+tachykinin+neuropeptides.&amp;rft.title=Science&amp;rft.jtitle=Science&amp;rft.date=1990&amp;rft.volume=250&amp;rft.issue=4978&amp;rft.au=Yankner+B%2C+Duffy+L%2C+Kirschner+D&amp;rft.pages=279-82">&#160;</span></li>
<li id="_note-Blanchard1"><b><a href="#_ref-Blanchard1_0" title="">^</a></b> <cite style="font-style:normal">Blanchard BJ, Hiniker AE, Lu CC, Margolin Y, Yu AS, Ingram VM (2000). "Elimination of Amyloid beta Neurotoxicity.". <i>J Alzheimers Dis</i> <b>2</b> (2): 137-149. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12214104" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12214104">PMID 12214104</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Elimination+of+Amyloid+beta+Neurotoxicity.&amp;rft.title=J+Alzheimers+Dis&amp;rft.jtitle=J+Alzheimers+Dis&amp;rft.date=2000&amp;rft.volume=2&amp;rft.issue=2&amp;rft.au=Blanchard+BJ%2C+Hiniker+AE%2C+Lu+CC%2C+Margolin+Y%2C+Yu+AS%2C+Ingram+VM&amp;rft.pages=137-149">&#160;</span></li>
<li id="_note-Blanchard2"><b><a href="#_ref-Blanchard2_0" title="">^</a></b> <cite style="font-style:normal">Blanchard B, Chen A, Rozeboom L, Stafford K, Weigele P, Ingram V (2004). "Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.". <i>Proc Natl Acad Sci U S A</i> <b>101</b> (40): 14326-32. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15388848" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15388848">PMID 15388848</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Efficient+reversal+of+Alzheimer%27s+disease+fibril+formation+and+elimination+of+neurotoxicity+by+a+small+molecule.&amp;rft.title=Proc+Natl+Acad+Sci+U+S+A&amp;rft.jtitle=Proc+Natl+Acad+Sci+U+S+A&amp;rft.date=2004&amp;rft.volume=101&amp;rft.issue=40&amp;rft.au=Blanchard+B%2C+Chen+A%2C+Rozeboom+L%2C+Stafford+K%2C+Weigele+P%2C+Ingram+V&amp;rft.pages=14326-32">&#160;</span></li>
<li id="_note-Porat"><b><a href="#_ref-Porat_0" title="">^</a></b> <cite style="font-style:normal">Porat Y, Abramowitz A, Gazit E (2006). "Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism.". <i>Chem Biol Drug Des</i> <b>67</b> (1): 27-37. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16492146" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16492146">PMID 16492146</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Inhibition+of+amyloid+fibril+formation+by+polyphenols%3A+structural+similarity+and+aromatic+interactions+as+a+common+inhibition+mechanism.&amp;rft.title=Chem+Biol+Drug+Des&amp;rft.jtitle=Chem+Biol+Drug+Des&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=1&amp;rft.au=Porat+Y%2C+Abramowitz+A%2C+Gazit+E&amp;rft.pages=27-37">&#160;</span></li>
<li id="_note-Kanapathipillai"><b><a href="#_ref-Kanapathipillai_0" title="">^</a></b> <cite style="font-style:normal">Kanapathipillai M, Lentzen G, Sierks M, Park C (2005). "Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.". <i>FEBS Lett</i> <b>579</b> (21): 4775-80. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16098972" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16098972">PMID 16098972</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Ectoine+and+hydroxyectoine+inhibit+aggregation+and+neurotoxicity+of+Alzheimer%27s+beta-amyloid.&amp;rft.title=FEBS+Lett&amp;rft.jtitle=FEBS+Lett&amp;rft.date=2005&amp;rft.volume=579&amp;rft.issue=21&amp;rft.au=Kanapathipillai+M%2C+Lentzen+G%2C+Sierks+M%2C+Park+C&amp;rft.pages=4775-80">&#160;</span></li>
<li id="_note-Lee"><b><a href="#_ref-Lee_0" title="">^</a></b> <cite style="font-style:normal">Lee K, Shin B, Shin K, Kim D, Yu J (2005). "A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42).". <i>Biochem Biophys Res Commun</i> <b>328</b> (4): 816-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15707952" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15707952">PMID 15707952</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+hybrid+molecule+that+prohibits+amyloid+fibrils+and+alleviates+neuronal+toxicity+induced+by+beta-amyloid+%281-42%29.&amp;rft.title=Biochem+Biophys+Res+Commun&amp;rft.jtitle=Biochem+Biophys+Res+Commun&amp;rft.date=2005&amp;rft.volume=328&amp;rft.issue=4&amp;rft.au=Lee+K%2C+Shin+B%2C+Shin+K%2C+Kim+D%2C+Yu+J&amp;rft.pages=816-23">&#160;</span></li>
<li id="_note-Espeseth"><b><a href="#_ref-Espeseth_0" title="">^</a></b> <cite style="font-style:normal">Espeseth A, Xu M, Huang Q, Coburn C, Jones K, Ferrer M, Zuck P, Strulovici B, Price E, Wu G, Wolfe A, Lineberger J, Sardana M, Tugusheva K, Pietrak B, Crouthamel M, Lai M, Dodson E, Bazzo R, Shi X, Simon A, Li Y, Hazuda D (2005). "Compounds that bind APP and inhibit Abeta processing <i>in vitro</i> suggest a novel approach to Alzheimer disease therapeutics.". <i>J Biol Chem</i> <b>280</b> (18): 17792-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15737955" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15737955">PMID 15737955</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Compounds+that+bind+APP+and+inhibit+Abeta+processing+%27%27in+vitro%27%27+suggest+a+novel+approach+to+Alzheimer+disease+therapeutics.&amp;rft.title=J+Biol+Chem&amp;rft.jtitle=J+Biol+Chem&amp;rft.date=2005&amp;rft.volume=280&amp;rft.issue=18&amp;rft.au=Espeseth+A%2C+Xu+M%2C+Huang+Q%2C+Coburn+C%2C+Jones+K%2C+Ferrer+M%2C+Zuck+P%2C+Strulovici+B%2C+Price+E%2C+Wu+G%2C+Wolfe+A%2C+Lineberger+J%2C+Sardana+M%2C+Tugusheva+K%2C+Pietrak+B%2C+Crouthamel+M%2C+Lai+M%2C+Dodson+E%2C+Bazzo+R%2C+Shi+X%2C+Simon+A%2C+Li+Y%2C+Hazuda+D&amp;rft.pages=17792-7">&#160;</span></li>
<li id="_note-8"><b><a href="#_ref-8" title="">^</a></b> <cite style="font-style:normal">Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995). "Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.". <i>N Engl J Med</i> <b>333</b> (19): 1242-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7566000" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7566000">PMID 7566000</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Apolipoprotein+E%2C+dementia%2C+and+cortical+deposition+of+beta-amyloid+protein.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=1995&amp;rft.volume=333&amp;rft.issue=19&amp;rft.au=Polvikoski+T%2C+Sulkava+R%2C+Haltia+M%2C+Kainulainen+K%2C+Vuorio+A%2C+Verkkoniemi+A%2C+Niinist%C3%B6+L%2C+Halonen+P%2C+Kontula+K&amp;rft.pages=1242-7">&#160;</span></li>
<li id="_note-9"><b><a href="#_ref-9" title="">^</a></b> <cite style="font-style:normal">Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F (1995). "Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.". <i>Nature</i> <b>373</b> (6514): 523-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7845465" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7845465">PMID 7845465</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alzheimer-type+neuropathology+in+transgenic+mice+overexpressing+V717F+beta-amyloid+precursor+protein.&amp;rft.title=Nature&amp;rft.jtitle=Nature&amp;rft.date=1995&amp;rft.volume=373&amp;rft.issue=6514&amp;rft.au=Games+D%2C+Adams+D%2C+Alessandrini+R%2C+Barbour+R%2C+Berthelette+P%2C+Blackwell+C%2C+Carr+T%2C+Clemens+J%2C+Donaldson+T%2C+Gillespie+F&amp;rft.pages=523-7">&#160;</span></li>
<li id="_note-10"><b><a href="#_ref-10" title="">^</a></b> <cite style="font-style:normal">Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996). "Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.". <i>J Neurosci</i> <b>16</b> (18): 5795-811. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8795633" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8795633">PMID 8795633</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Comparison+of+neurodegenerative+pathology+in+transgenic+mice+overexpressing+V717F+beta-amyloid+precursor+protein+and+Alzheimer%27s+disease.&amp;rft.title=J+Neurosci&amp;rft.jtitle=J+Neurosci&amp;rft.date=1996&amp;rft.volume=16&amp;rft.issue=18&amp;rft.au=Masliah+E%2C+Sisk+A%2C+Mallory+M%2C+Mucke+L%2C+Schenk+D%2C+Games+D&amp;rft.pages=5795-811">&#160;</span></li>
<li id="_note-11"><b><a href="#_ref-11" title="">^</a></b> <cite style="font-style:normal">Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996). "Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.". <i>Science</i> <b>274</b> (5284): 99-102. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8810256" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8810256">PMID 8810256</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Correlative+memory+deficits%2C+Abeta+elevation%2C+and+amyloid+plaques+in+transgenic+mice.&amp;rft.title=Science&amp;rft.jtitle=Science&amp;rft.date=1996&amp;rft.volume=274&amp;rft.issue=5284&amp;rft.au=Hsiao+K%2C+Chapman+P%2C+Nilsen+S%2C+Eckman+C%2C+Harigaya+Y%2C+Younkin+S%2C+Yang+F%2C+Cole+G&amp;rft.pages=99-102">&#160;</span></li>
<li id="_note-Vetrivel"><b><a href="#_ref-Vetrivel_0" title="">^</a></b> <cite style="font-style:normal">Vetrivel KS, Zhang YW, Xu H, Thinakaran G. (2006). "Pathological and physiological functions of presenilins.". <i>Mol Neurodegener</i> <b>12</b>: 1-4. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16930451" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16930451">PMID 16930451</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Pathological+and+physiological+functions+of+presenilins.&amp;rft.title=Mol+Neurodegener&amp;rft.jtitle=Mol+Neurodegener&amp;rft.date=2006&amp;rft.volume=12&amp;rft.au=Vetrivel+KS%2C+Zhang+YW%2C+Xu+H%2C+Thinakaran+G.&amp;rft.pages=1-4">&#160;</span></li>
<li id="_note-12"><b><a href="#_ref-12" title="">^</a></b> <cite style="font-style:normal">Wang R, Dineley K, Sweatt J, Zheng H (2004). "Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis.". <i>Neuroscience</i> <b>126</b> (2): 305-12. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15207348" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15207348">PMID 15207348</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Presenilin+1+familial+Alzheimer%27s+disease+mutation+leads+to+defective+associative+learning+and+impaired+adult+neurogenesis.&amp;rft.title=Neuroscience&amp;rft.jtitle=Neuroscience&amp;rft.date=2004&amp;rft.volume=126&amp;rft.issue=2&amp;rft.au=Wang+R%2C+Dineley+K%2C+Sweatt+J%2C+Zheng+H&amp;rft.pages=305-12">&#160;</span></li>
<li id="_note-Jellinger"><b><a href="#_ref-Jellinger_0" title="">^</a></b> <cite style="font-style:normal">Jellinger KA (2006). "Head injury and dementia.". <i>Curr Opin Neurol</i> <b>17</b> (6): 719-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15542981" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15542981">PMID 15542981</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Head+injury+and+dementia.&amp;rft.title=Curr+Opin+Neurol&amp;rft.jtitle=Curr+Opin+Neurol&amp;rft.date=2006&amp;rft.volume=17&amp;rft.issue=6&amp;rft.au=Jellinger+KA&amp;rft.pages=719-23">&#160;</span></li>
<li id="_note-Guskiewicz"><b><a href="#_ref-Guskiewicz_0" title="">^</a></b> <cite style="font-style:normal">Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Cantu RC, Randolph C, Jordan BD (2006). "Association between recurrent concussion and late-life cognitive impairment in retired professional football players.". <i>Neurosurgery</i> <b>57</b> (4): 719-26. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16239884" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16239884">PMID 16239884</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Association+between+recurrent+concussion+and+late-life+cognitive+impairment+in+retired+professional+football+players.&amp;rft.title=Neurosurgery&amp;rft.jtitle=Neurosurgery&amp;rft.date=2006&amp;rft.volume=57&amp;rft.issue=4&amp;rft.au=Guskiewicz+KM%2C+Marshall+SW%2C+Bailes+J%2C+McCrea+M%2C+Cantu+RC%2C+Randolph+C%2C+Jordan+BD&amp;rft.pages=719-26">&#160;</span></li>
<li id="_note-Tyas">^ <a href="#_ref-Tyas_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Tyas_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Tyas SL, Manfreda J, Strain LA, Montgomery PR. (2001). "Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.". <i>Int J Epidemiol</i> <b>30</b> (3): 590-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11416089" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11416089">PMID 11416089</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Risk+factors+for+Alzheimer%27s+disease%3A+a+population-based%2C+longitudinal+study+in+Manitoba%2C+Canada.&amp;rft.title=Int+J+Epidemiol&amp;rft.jtitle=Int+J+Epidemiol&amp;rft.date=2001&amp;rft.volume=30&amp;rft.issue=3&amp;rft.au=Tyas+SL%2C+Manfreda+J%2C+Strain+LA%2C+Montgomery+PR.&amp;rft.pages=590-7">&#160;</span></li>
<li id="_note-Munoz"><b><a href="#_ref-Munoz_0" title="">^</a></b> <cite style="font-style:normal">Munoz DG, Feldman H. (2000). "Causes of Alzheimer's disease.". <i>CMAJ</i> <b>162</b> (1): 65-72. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11216203" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11216203">PMID 11216203</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Causes+of+Alzheimer%27s+disease.&amp;rft.title=CMAJ&amp;rft.jtitle=CMAJ&amp;rft.date=2000&amp;rft.volume=162&amp;rft.issue=1&amp;rft.au=Munoz+DG%2C+Feldman+H.&amp;rft.pages=65-72">&#160;</span></li>
<li id="_note-13"><b><a href="#_ref-13" title="">^</a></b> <cite style="font-style:normal">Lahiri D, Ghosh C, Ge Y. "A proximal gene promoter region for the beta-amyloid precursor protein provides a link between development, apoptosis, and Alzheimer's disease.". <i>Ann N Y Acad Sci</i> <b>1010</b>: 643-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15033805" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15033805">PMID 15033805</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=A+proximal+gene+promoter+region+for+the+beta-amyloid+precursor+protein+provides+a+link+between+development%2C+apoptosis%2C+and+Alzheimer%27s+disease.&amp;rft.title=Ann+N+Y+Acad+Sci&amp;rft.jtitle=Ann+N+Y+Acad+Sci&amp;rft.volume=1010&amp;rft.au=Lahiri+D%2C+Ghosh+C%2C+Ge+Y&amp;rft.pages=643-7">&#160;</span></li>
<li id="_note-14"><b><a href="#_ref-14" title="">^</a></b> <cite style="font-style:normal">Cacabelos R, Fernandez-Novoa L, Lombardi V, Kubota Y, Takeda M. "Molecular genetics of Alzheimer's disease and aging.". <i>Methods Find Exp Clin Pharmacol</i> <b>27 Suppl A</b>: 1-573. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16470248" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16470248">PMID 16470248</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Molecular+genetics+of+Alzheimer%27s+disease+and+aging.&amp;rft.title=Methods+Find+Exp+Clin+Pharmacol&amp;rft.jtitle=Methods+Find+Exp+Clin+Pharmacol&amp;rft.volume=27+Suppl+A&amp;rft.au=Cacabelos+R%2C+Fernandez-Novoa+L%2C+Lombardi+V%2C+Kubota+Y%2C+Takeda+M&amp;rft.pages=1-573">&#160;</span></li>
<li id="_note-15"><b><a href="#_ref-15" title="">^</a></b> <cite style="font-style:normal">Nowotny P, Hinrichs A, Smemo S, Kauwe J, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P, Moore P, Bryden L, Myers A, Doil L, Tacey K, Gibson A, McKeith I, Perry R, Morris C, Thal L, Morris J, O'Donovan M, Lovestone S, Grupe A, Hardy J, Owen M, Williams J, Goate A (2005). "Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.". <i>Am J Med Genet B Neuropsychiatr Genet</i> <b>136</b> (1): 62-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15858813" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15858813">PMID 15858813</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Association+studies+between+risk+for+late-onset+Alzheimer%27s+disease+and+variants+in+insulin+degrading+enzyme.&amp;rft.title=Am+J+Med+Genet+B+Neuropsychiatr+Genet&amp;rft.jtitle=Am+J+Med+Genet+B+Neuropsychiatr+Genet&amp;rft.date=2005&amp;rft.volume=136&amp;rft.issue=1&amp;rft.au=Nowotny+P%2C+Hinrichs+A%2C+Smemo+S%2C+Kauwe+J%2C+Maxwell+T%2C+Holmans+P%2C+Hamshere+M%2C+Turic+D%2C+Jehu+L%2C+Hollingworth+P%2C+Moore+P%2C+Bryden+L%2C+Myers+A%2C+Doil+L%2C+Tacey+K%2C+Gibson+A%2C+McKeith+I%2C+Perry+R%2C+Morris+C%2C+Thal+L%2C+Morris+J%2C+O%27Donovan+M%2C+Lovestone+S%2C+Grupe+A%2C+Hardy+J%2C+Owen+M%2C+Williams+J%2C+Goate+A&amp;rft.pages=62-8">&#160;</span></li>
<li id="_note-16"><b><a href="#_ref-16" title="">^</a></b> <cite style="font-style:normal">Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Léonard N, Codron V, David J, Amouyel P, Schwartz J, Helbecque N (2004). "Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.". <i>Mol Psychiatry</i> <b>9</b> (12): 1122-8, 1059. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15340356" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15340356">PMID 15340356</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Endothelin-converting+enzyme-1+is+expressed+in+human+cerebral+cortex+and+protects+against+Alzheimer%27s+disease.&amp;rft.title=Mol+Psychiatry&amp;rft.jtitle=Mol+Psychiatry&amp;rft.date=2004&amp;rft.volume=9&amp;rft.issue=12&amp;rft.au=Funalot+B%2C+Ouimet+T%2C+Claperon+A%2C+Fallet+C%2C+Delacourte+A%2C+Epelbaum+J%2C+Subkowski+T%2C+L%C3%A9onard+N%2C+Codron+V%2C+David+J%2C+Amouyel+P%2C+Schwartz+J%2C+Helbecque+N&amp;rft.pages=1122-8%2C+1059">&#160;</span></li>
<li id="_note-17"><b><a href="#_ref-17" title="">^</a></b> <cite style="font-style:normal">Manev H, Manev R (2006). "5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.". <i>Med Hypotheses</i> <b>66</b> (3): 501-3. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16278051" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16278051">PMID 16278051</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=5-Lipoxygenase+%28ALOX5%29+and+FLAP+%28ALOX5AP%29+gene+polymorphisms+as+factors+in+vascular+pathology+and+Alzheimer%27s+disease.&amp;rft.title=Med+Hypotheses&amp;rft.jtitle=Med+Hypotheses&amp;rft.date=2006&amp;rft.volume=66&amp;rft.issue=3&amp;rft.au=Manev+H%2C+Manev+R&amp;rft.pages=501-3">&#160;</span></li>
<li id="_note-18"><b><a href="#_ref-18" title="">^</a></b> Van Broeckhoven C, Backhovens H, Cruts M, De Winter G, Bruyland M, Cras P, Martin JJ., Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3, Nat Genet. 1992 Dec;2(4):335-9.</li>
<li id="_note-19"><b><a href="#_ref-19" title="">^</a></b> <cite style="font-style:normal">Gorelick P (2004). "Risk factors for vascular dementia and Alzheimer disease.". <i>Stroke</i> <b>35</b> (11 Suppl 1): 2620-2. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15375299" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15375299">PMID 15375299</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Risk+factors+for+vascular+dementia+and+Alzheimer+disease.&amp;rft.title=Stroke&amp;rft.jtitle=Stroke&amp;rft.date=2004&amp;rft.volume=35&amp;rft.issue=11+Suppl+1&amp;rft.au=Gorelick+P&amp;rft.pages=2620-2">&#160;</span></li>
<li id="_note-20"><b><a href="#_ref-20" title="">^</a></b> <cite style="font-style:normal">Hebert L, Scherr P, Bienias J, Bennett D, Evans D (2003). "Alzheimer disease in the US population: prevalence estimates using the 2000 census.". <i>Arch Neurol</i> <b>60</b> (8): 1119-22. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12925369" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12925369">PMID 12925369</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Alzheimer+disease+in+the+US+population%3A+prevalence+estimates+using+the+2000+census.&amp;rft.title=Arch+Neurol&amp;rft.jtitle=Arch+Neurol&amp;rft.date=2003&amp;rft.volume=60&amp;rft.issue=8&amp;rft.au=Hebert+L%2C+Scherr+P%2C+Bienias+J%2C+Bennett+D%2C+Evans+D&amp;rft.pages=1119-22">&#160;</span></li>
<li id="_note-21"><b><a href="#_ref-21" title="">^</a></b> <cite style="font-style:normal">Small, Gary W (<a href="../../../2/0/0/2002.html" title="2002">2002</a>-<a href="../../../j/u/n/June_22.html" title="June 22">06-22</a>). "<a href="http://bmj.bmjjournals.com/cgi/content/full/324/7352/1502#B21" class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/324/7352/1502#B21" rel="nofollow">What we need to know about age related memory loss</a>". <i>British Medical Journal</i>: 1502-1507. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../n/o/v/November_5.html" title="November 5">11-05</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=What+we+need+to+know+about+age+related+memory+loss&amp;rft.title=British+Medical+Journal&amp;rft.jtitle=British+Medical+Journal&amp;rft.date=%5B%5B2002-06-22%5D%5D&amp;rft.aulast=Small&amp;rft.aufirst=Gary+W&amp;rft.pages=1502-1507&amp;rft_id=http%3A%2F%2Fbmj.bmjjournals.com%2Fcgi%2Fcontent%2Ffull%2F324%2F7352%2F1502%23B21">&#160;</span></li>
<li id="_note-22"><b><a href="#_ref-22" title="">^</a></b> <cite style="font-style:normal">Verghese J, Lipton R, Katz M, Hall C, Derby C, Kuslansky G, Ambrose A, Sliwinski M, Buschke H (2003). "Leisure activities and the risk of dementia in the elderly.". <i>N Engl J Med</i> <b>348</b> (25): 2508-16. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12815136" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12815136">PMID 12815136</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Leisure+activities+and+the+risk+of+dementia+in+the+elderly.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2003&amp;rft.volume=348&amp;rft.issue=25&amp;rft.au=Verghese+J%2C+Lipton+R%2C+Katz+M%2C+Hall+C%2C+Derby+C%2C+Kuslansky+G%2C+Ambrose+A%2C+Sliwinski+M%2C+Buschke+H&amp;rft.pages=2508-16">&#160;</span></li>
<li id="_note-23"><b><a href="#_ref-23" title="">^</a></b> <cite style="font-style:normal">Larson E, Wang L, Bowen J, McCormick W, Teri L, Crane P, Kukull W (2006). "Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older.". <i>Ann Intern Med</i> <b>144</b> (2): 73-81. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16418406" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16418406">PMID 16418406</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Exercise+is+associated+with+reduced+risk+for+incident+dementia+among+persons+65+years+of+age+and+older.&amp;rft.title=Ann+Intern+Med&amp;rft.jtitle=Ann+Intern+Med&amp;rft.date=2006&amp;rft.volume=144&amp;rft.issue=2&amp;rft.au=Larson+E%2C+Wang+L%2C+Bowen+J%2C+McCormick+W%2C+Teri+L%2C+Crane+P%2C+Kukull+W&amp;rft.pages=73-81">&#160;</span></li>
<li id="_note-24"><b><a href="#_ref-24" title="">^</a></b> <cite style="font-style:normal">Scarmeas N, Stern Y, Mayeux R, Luchsinger J (2006). "Mediterranean diet, Alzheimer disease, and vascular mediation.". <i>Arch Neurol</i> <b>63</b> (12): 1709-17. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17030648" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17030648">PMID 17030648</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Mediterranean+diet%2C+Alzheimer+disease%2C+and+vascular+mediation.&amp;rft.title=Arch+Neurol&amp;rft.jtitle=Arch+Neurol&amp;rft.date=2006&amp;rft.volume=63&amp;rft.issue=12&amp;rft.au=Scarmeas+N%2C+Stern+Y%2C+Mayeux+R%2C+Luchsinger+J&amp;rft.pages=1709-17">&#160;</span></li>
<li id="_note-25"><b><a href="#_ref-25" title="">^</a></b> <cite style="font-style:normal">Morris M, Schneider J, Tangney C (2006). "Thoughts on B-vitamins and dementia.". <i>J Alzheimers Dis</i> <b>9</b> (4): 429-33. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16917152" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16917152">PMID 16917152</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Thoughts+on+B-vitamins+and+dementia.&amp;rft.title=J+Alzheimers+Dis&amp;rft.jtitle=J+Alzheimers+Dis&amp;rft.date=2006&amp;rft.volume=9&amp;rft.issue=4&amp;rft.au=Morris+M%2C+Schneider+J%2C+Tangney+C&amp;rft.pages=429-33">&#160;</span></li>
<li id="_note-26"><b><a href="#_ref-26" title="">^</a></b> <cite style="font-style:normal">Lim W, Gammack J, Van Niekerk J, Dangour A. "Omega 3 fatty acid for the prevention of dementia.". <i>Cochrane Database Syst Rev</i>: CD005379. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16437528" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16437528">PMID 16437528</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Omega+3+fatty+acid+for+the+prevention+of+dementia.&amp;rft.title=Cochrane+Database+Syst+Rev&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.au=Lim+W%2C+Gammack+J%2C+Van+Niekerk+J%2C+Dangour+A&amp;rft.pages=CD005379">&#160;</span></li>
<li id="_note-27"><b><a href="#_ref-27" title="">^</a></b> <cite style="font-style:normal">Morris M, Evans D, Tangney C, Bienias J, Wilson R (2005). "Fish consumption and cognitive decline with age in a large community study.". <i>Arch Neurol</i> <b>62</b> (12): 1849-53. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16216930" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16216930">PMID 16216930</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Fish+consumption+and+cognitive+decline+with+age+in+a+large+community+study.&amp;rft.title=Arch+Neurol&amp;rft.jtitle=Arch+Neurol&amp;rft.date=2005&amp;rft.volume=62&amp;rft.issue=12&amp;rft.au=Morris+M%2C+Evans+D%2C+Tangney+C%2C+Bienias+J%2C+Wilson+R&amp;rft.pages=1849-53">&#160;</span></li>
<li id="_note-28"><b><a href="#_ref-28" title="">^</a></b> <cite style="font-style:normal">Dai Q, Borenstein A, Wu Y, Jackson J, Larson E (2006). "Fruit and vegetable juices and Alzheimer's disease: the Kame Project.". <i>Am J Med</i> <b>119</b> (9): 751-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16945610" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16945610">PMID 16945610</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Fruit+and+vegetable+juices+and+Alzheimer%27s+disease%3A+the+Kame+Project.&amp;rft.title=Am+J+Med&amp;rft.jtitle=Am+J+Med&amp;rft.date=2006&amp;rft.volume=119&amp;rft.issue=9&amp;rft.au=Dai+Q%2C+Borenstein+A%2C+Wu+Y%2C+Jackson+J%2C+Larson+E&amp;rft.pages=751-9">&#160;</span></li>
<li id="_note-29"><b><a href="#_ref-29" title="">^</a></b> <cite style="font-style:normal">Joseph J, Fisher D, Carey A (2004). "Fruit extracts antagonize Abeta- or DA-induced deficits in Ca2+ flux in M1-transfected COS-7 cells.". <i>J Alzheimers Dis</i> <b>6</b> (4): 403-11; discussion 443-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15345811" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15345811">PMID 15345811</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Fruit+extracts+antagonize+Abeta-+or+DA-induced+deficits+in+Ca2%2B+flux+in+M1-transfected+COS-7+cells.&amp;rft.title=J+Alzheimers+Dis&amp;rft.jtitle=J+Alzheimers+Dis&amp;rft.date=2004&amp;rft.volume=6&amp;rft.issue=4&amp;rft.au=Joseph+J%2C+Fisher+D%2C+Carey+A&amp;rft.pages=403-11%3B+discussion+443-9">&#160;</span></li>
<li id="_note-30"><b><a href="#_ref-30" title="">^</a></b> <cite style="font-style:normal">Petersen R, Thomas R, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck C, Thal L (2005). "Vitamin E and donepezil for the treatment of mild cognitive impairment.". <i>N Engl J Med</i> <b>352</b> (23): 2379-88. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15829527" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15829527">PMID 15829527</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Vitamin+E+and+donepezil+for+the+treatment+of+mild+cognitive+impairment.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2005&amp;rft.volume=352&amp;rft.issue=23&amp;rft.au=Petersen+R%2C+Thomas+R%2C+Grundman+M%2C+Bennett+D%2C+Doody+R%2C+Ferris+S%2C+Galasko+D%2C+Jin+S%2C+Kaye+J%2C+Levey+A%2C+Pfeiffer+E%2C+Sano+M%2C+van+Dyck+C%2C+Thal+L&amp;rft.pages=2379-88">&#160;</span></li>
<li id="_note-31"><b><a href="#_ref-31" title="">^</a></b> <cite style="font-style:normal">Zandi P, Anthony J, Khachaturian A, Stone S, Gustafson D, Tschanz J, Norton M, Welsh-Bohmer K, Breitner J (2004). "Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.". <i>Arch Neurol</i> <b>61</b> (1): 82-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14732624" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14732624">PMID 14732624</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Reduced+risk+of+Alzheimer+disease+in+users+of+antioxidant+vitamin+supplements%3A+the+Cache+County+Study.&amp;rft.title=Arch+Neurol&amp;rft.jtitle=Arch+Neurol&amp;rft.date=2004&amp;rft.volume=61&amp;rft.issue=1&amp;rft.au=Zandi+P%2C+Anthony+J%2C+Khachaturian+A%2C+Stone+S%2C+Gustafson+D%2C+Tschanz+J%2C+Norton+M%2C+Welsh-Bohmer+K%2C+Breitner+J&amp;rft.pages=82-8">&#160;</span></li>
<li id="_note-32"><b><a href="#_ref-32" title="">^</a></b> <cite style="font-style:normal">Rockwood K. "Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease.". <i>Acta Neurol Scand Suppl</i> <b>185</b>: 71-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16866914" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16866914">PMID 16866914</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Epidemiological+and+clinical+trials+evidence+about+a+preventive+role+for+statins+in+Alzheimer%27s+disease.&amp;rft.title=Acta+Neurol+Scand+Suppl&amp;rft.jtitle=Acta+Neurol+Scand+Suppl&amp;rft.volume=185&amp;rft.au=Rockwood+K&amp;rft.pages=71-7">&#160;</span></li>
<li id="_note-33"><b><a href="#_ref-33" title="">^</a></b> <cite style="font-style:normal">Zandi P, Anthony J, Hayden K, Mehta K, Mayer L, Breitner J (2002). "Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study". <i>Neurology</i> <b>59</b> (6): 880-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12297571" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12297571">PMID 12297571</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Reduced+incidence+of+AD+with+NSAID+but+not+H2+receptor+antagonists%3A+the+Cache+County+Study&amp;rft.title=Neurology&amp;rft.jtitle=Neurology&amp;rft.date=2002&amp;rft.volume=59&amp;rft.issue=6&amp;rft.au=Zandi+P%2C+Anthony+J%2C+Hayden+K%2C+Mehta+K%2C+Mayer+L%2C+Breitner+J&amp;rft.pages=880-6">&#160;</span></li>
<li id="_note-34"><b><a href="#_ref-34" title="">^</a></b> <cite style="font-style:normal">in t' Veld B, Ruitenberg A, Hofman A, Launer L, van Duijn C, Stijnen T, Breteler M, Stricker B (2001). "Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease". <i>N Engl J Med</i> <b>345</b> (21): 1515-21. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11794217" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11794217">PMID 11794217</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Nonsteroidal+antiinflammatory+drugs+and+the+risk+of+Alzheimer%27s+disease&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2001&amp;rft.volume=345&amp;rft.issue=21&amp;rft.au=in+t%27+Veld+B%2C+Ruitenberg+A%2C+Hofman+A%2C+Launer+L%2C+van+Duijn+C%2C+Stijnen+T%2C+Breteler+M%2C+Stricker+B&amp;rft.pages=1515-21">&#160;</span></li>
<li id="_note-2006AAGP">^ <a href="#_ref-2006AAGP_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-2006AAGP_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-2006AAGP_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-2006AAGP_3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal">Lyketsos C, Colenda C, Beck C, Blank K, Doraiswamy M, Kalunian D, Yaffe K (2006). "Position statement of the American Association for Geriatric Psychiatry (AAGP) regarding principles of care for patients with dementia resulting from Alzheimer disease.". <i>Am J Geriatr Psychiatry</i> <b>14</b> (7): 561-72. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16816009" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16816009">PMID 16816009</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Position+statement+of+the+American+Association+for+Geriatric+Psychiatry+%28AAGP%29+regarding+principles+of+care+for+patients+with+dementia+resulting+from+Alzheimer+disease.&amp;rft.title=Am+J+Geriatr+Psychiatry&amp;rft.jtitle=Am+J+Geriatr+Psychiatry&amp;rft.date=2006&amp;rft.volume=14&amp;rft.issue=7&amp;rft.au=Lyketsos+C%2C+Colenda+C%2C+Beck+C%2C+Blank+K%2C+Doraiswamy+M%2C+Kalunian+D%2C+Yaffe+K&amp;rft.pages=561-72">&#160;</span> <a href="http://ajgp.org/cgi/content/full/14/7/561" class="external autonumber" title="http://ajgp.org/cgi/content/full/14/7/561" rel="nofollow">[1]</a></li>
<li id="_note-35"><b><a href="#_ref-35" title="">^</a></b> <cite style="font-style:normal">Ramirez et al (2005). "Prevention of Alzheimer's Disease pathology by cannabinoids". <i>The Journal of Neuroscience</i> <b>25</b> (8): 1904-13.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Prevention+of+Alzheimer%27s+Disease+pathology+by+cannabinoids&amp;rft.title=The+Journal+of+Neuroscience&amp;rft.jtitle=The+Journal+of+Neuroscience&amp;rft.date=2005&amp;rft.volume=25&amp;rft.issue=8&amp;rft.au=Ramirez+et+al&amp;rft.pages=1904-13">&#160;</span> <a href="http://www.jneurosci.org/cgi/content/abstract/25/8/1904" class="external autonumber" title="http://www.jneurosci.org/cgi/content/abstract/25/8/1904" rel="nofollow">[2]</a></li>
<li id="_note-36"><b><a href="#_ref-36" title="">^</a></b> <cite style="font-style:normal">Rosario E, Carroll J, Oddo S, LaFerla F, Pike C (2006). "Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease.". <i>J Neurosci</i> <b>26</b> (51): 13384-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17182789" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17182789">PMID 17182789</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Androgens+regulate+the+development+of+neuropathology+in+a+triple+transgenic+mouse+model+of+Alzheimer%27s+disease.&amp;rft.title=J+Neurosci&amp;rft.jtitle=J+Neurosci&amp;rft.date=2006&amp;rft.volume=26&amp;rft.issue=51&amp;rft.au=Rosario+E%2C+Carroll+J%2C+Oddo+S%2C+LaFerla+F%2C+Pike+C&amp;rft.pages=13384-9">&#160;</span></li>
<li id="_note-37"><b><a href="#_ref-37" title="">^</a></b> <a href="http://www.niehs.nih.gov/external/faq/aluminum.htm" class="external text" title="http://www.niehs.nih.gov/external/faq/aluminum.htm" rel="nofollow">Alzheimer's Disease and Aluminum - NIEHS Alphabetical Listing of Health Topics</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../s/e/p/September_20.html" title="September 20">09-20</a>.</li>
<li id="_note-38"><b><a href="#_ref-38" title="">^</a></b> <cite style="font-style:normal">Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini P (2006). "Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.". <i>Neurology</i> <b>67</b> (1): 76-82. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16832081" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16832081">PMID 16832081</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Excess+of+nonceruloplasmin+serum+copper+in+AD+correlates+with+MMSE%2C+CSF+%5Bbeta%5D-amyloid%2C+and+h-tau.&amp;rft.title=Neurology&amp;rft.jtitle=Neurology&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=1&amp;rft.au=Squitti+R%2C+Barbati+G%2C+Rossi+L%2C+Ventriglia+M%2C+Dal+Forno+G%2C+Cesaretti+S%2C+Moffa+F%2C+Caridi+I%2C+Cassetta+E%2C+Pasqualetti+P%2C+Calabrese+L%2C+Lupoi+D%2C+Rossini+P&amp;rft.pages=76-82">&#160;</span></li>
<li id="_note-39"><b><a href="#_ref-39" title="">^</a></b> <a href="http://jnnp.bmjjournals.com/cgi/content/extract/77/7/811" class="external text" title="http://jnnp.bmjjournals.com/cgi/content/extract/77/7/811" rel="nofollow">Exposure to aluminium and the subsequent development of a disorder with features of Alzheimer’s disease</a>.</li>
<li id="_note-40"><b><a href="#_ref-40" title="">^</a></b> <a href="http://jnnp.bmj.com/cgi/eletters/77/7/811#971" class="external text" title="http://jnnp.bmj.com/cgi/eletters/77/7/811#971" rel="nofollow">Alzheimer's Dementia and Aluminum in Drinking Water</a></li>
<li id="_note-41"><b><a href="#_ref-41" title="">^</a></b> Ortho-McNeil Neurologics, “Razadyne ER US Product Insert”, May 2006. <a href="http://www.razadyne.com/active/janus/en_US/assets/common/company/pi/razadyne.pdf" class="external autonumber" title="http://www.razadyne.com/active/janus/en_US/assets/common/company/pi/razadyne.pdf" rel="nofollow">[3]</a></li>
<li id="_note-42"><b><a href="#_ref-42" title="">^</a></b> Novartis Pharmaceuticals Corporation “Exelon Product Insert” June 2006. <a href="http://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf" class="external autonumber" title="http://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf" rel="nofollow">[4]</a></li>
<li id="_note-43"><b><a href="#_ref-43" title="">^</a></b> Eisai Inc, “Aricept and Aricept ODT Product Insert”, March 2005. <a href="http://www.aricept.com/content/pi.pdf" class="external autonumber" title="http://www.aricept.com/content/pi.pdf" rel="nofollow">[5]</a></li>
<li id="_note-44"><b><a href="#_ref-44" title="">^</a></b> <cite style="font-style:normal">Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P (2004). "Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.". <i>Lancet</i> <b>363</b> (9427): 2105-15. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15220031" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15220031">PMID 15220031</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Long-term+donepezil+treatment+in+565+patients+with+Alzheimer%27s+disease+%28AD2000%29%3A+randomised+double-blind+trial.&amp;rft.title=Lancet&amp;rft.jtitle=Lancet&amp;rft.date=2004&amp;rft.volume=363&amp;rft.issue=9427&amp;rft.au=Courtney+C%2C+Farrell+D%2C+Gray+R%2C+Hills+R%2C+Lynch+L%2C+Sellwood+E%2C+Edwards+S%2C+Hardyman+W%2C+Raftery+J%2C+Crome+P%2C+Lendon+C%2C+Shaw+H%2C+Bentham+P&amp;rft.pages=2105-15">&#160;</span></li>
<li id="_note-45"><b><a href="#_ref-45" title="">^</a></b> <cite style="font-style:normal">Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt H, van den Bussche H (2005). "Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.". <i>BMJ</i> <b>331</b> (7512): 321-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16081444" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16081444">PMID 16081444</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Cholinesterase+inhibitors+for+patients+with+Alzheimer%27s+disease%3A+systematic+review+of+randomised+clinical+trials.&amp;rft.title=BMJ&amp;rft.jtitle=BMJ&amp;rft.date=2005&amp;rft.volume=331&amp;rft.issue=7512&amp;rft.au=Kaduszkiewicz+H%2C+Zimmermann+T%2C+Beck-Bornholdt+H%2C+van+den+Bussche+H&amp;rft.pages=321-7">&#160;</span></li>
<li id="_note-46"><b><a href="#_ref-46" title="">^</a></b> <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=47681" class="external text" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=47681" rel="nofollow">Exelon Patch, The First Transdermal Therapy For Alzheimer's Disease, May Provide Promising New Approach To Treatment Of Dementia</a></li>
<li id="_note-alzheim"><b><a href="#_ref-alzheim_0" title="">^</a></b> <cite style="font-style:normal">Birks J, Grimley E, Van Dongen M. "Ginkgo biloba for cognitive impairment and dementia.". <i>Cochrane Database Syst Rev</i>: CD003120. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12519586" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12519586">PMID 12519586</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Ginkgo+biloba+for+cognitive+impairment+and+dementia.&amp;rft.title=Cochrane+Database+Syst+Rev&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.au=Birks+J%2C+Grimley+E%2C+Van+Dongen+M&amp;rft.pages=CD003120">&#160;</span>.</li>
<li id="_note-47"><b><a href="#_ref-47" title="">^</a></b> <cite style="font-style:normal">DeKosky S, Fitzpatrick A, Ives D, Saxton J, Williamson J, Lopez O, Burke G, Fried L, Kuller L, Robbins J, Tracy R, Woolard N, Dunn L, Kronmal R, Nahin R, Furberg C (2006). "The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.". <i>Contemp Clin Trials</i> <b>27</b> (3): 238-53. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16627007" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16627007">PMID 16627007</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+Ginkgo+Evaluation+of+Memory+%28GEM%29+study%3A+design+and+baseline+data+of+a+randomized+trial+of+Ginkgo+biloba+extract+in+prevention+of+dementia.&amp;rft.title=Contemp+Clin+Trials&amp;rft.jtitle=Contemp+Clin+Trials&amp;rft.date=2006&amp;rft.volume=27&amp;rft.issue=3&amp;rft.au=DeKosky+S%2C+Fitzpatrick+A%2C+Ives+D%2C+Saxton+J%2C+Williamson+J%2C+Lopez+O%2C+Burke+G%2C+Fried+L%2C+Kuller+L%2C+Robbins+J%2C+Tracy+R%2C+Woolard+N%2C+Dunn+L%2C+Kronmal+R%2C+Nahin+R%2C+Furberg+C&amp;rft.pages=238-53">&#160;</span>.</li>
<li id="_note-Areosa"><b><a href="#_ref-Areosa_0" title="">^</a></b> <cite style="font-style:normal">Areosa Sastre A, McShane R, Sherriff F. "Memantine for dementia.". <i>Cochrane Database Syst Rev</i>: CD003154. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15495043" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15495043">PMID 15495043</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Memantine+for+dementia.&amp;rft.title=Cochrane+Database+Syst+Rev&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.au=Areosa+Sastre+A%2C+McShane+R%2C+Sherriff+F&amp;rft.pages=CD003154">&#160;</span></li>
<li id="_note-48"><b><a href="#_ref-48" title="">^</a></b> <cite style="font-style:normal">Olazarán J, Muñiz R, Reisberg B, Peña-Casanova J, del Ser T, Cruz-Jentoft A, Serrano P, Navarro E, García de la Rocha M, Frank A, Galiano M, Fernández-Bullido Y, Serra J, González-Salvador M, Sevilla C (2004). "Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.". <i>Neurology</i> <b>63</b> (12): 2348-53. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15623698" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15623698">PMID 15623698</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Benefits+of+cognitive-motor+intervention+in+MCI+and+mild+to+moderate+Alzheimer+disease.&amp;rft.title=Neurology&amp;rft.jtitle=Neurology&amp;rft.date=2004&amp;rft.volume=63&amp;rft.issue=12&amp;rft.au=Olazar%C3%A1n+J%2C+Mu%C3%B1iz+R%2C+Reisberg+B%2C+Pe%C3%B1a-Casanova+J%2C+del+Ser+T%2C+Cruz-Jentoft+A%2C+Serrano+P%2C+Navarro+E%2C+Garc%C3%ADa+de+la+Rocha+M%2C+Frank+A%2C+Galiano+M%2C+Fern%C3%A1ndez-Bullido+Y%2C+Serra+J%2C+Gonz%C3%A1lez-Salvador+M%2C+Sevilla+C&amp;rft.pages=2348-53">&#160;</span></li>
<li id="_note-49"><b><a href="#_ref-49" title="">^</a></b> <cite style="font-style:normal">Clare L, Woods R, Moniz Cook E, Orrell M, Spector A. "Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia.". <i>Cochrane Database Syst Rev</i>: CD003260. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14583963" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14583963">PMID 14583963</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Cognitive+rehabilitation+and+cognitive+training+for+early-stage+Alzheimer%27s+disease+and+vascular+dementia.&amp;rft.title=Cochrane+Database+Syst+Rev&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.au=Clare+L%2C+Woods+R%2C+Moniz+Cook+E%2C+Orrell+M%2C+Spector+A&amp;rft.pages=CD003260">&#160;</span></li>
<li id="_note-50"><b><a href="#_ref-50" title="">^</a></b> <cite style="font-style:normal">Lemaire L, Fournier J, Ponthus C, Le Fur Y, Confort-Gouny S, Vion-Dury J, Keane P, Cozzone P (2002). "Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.". <i>Invest Radiol</i> <b>37</b> (6): 321-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12021588" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12021588">PMID 12021588</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Magnetic+resonance+imaging+of+the+neuroprotective+effect+of+xaliproden+in+rats.&amp;rft.title=Invest+Radiol&amp;rft.jtitle=Invest+Radiol&amp;rft.date=2002&amp;rft.volume=37&amp;rft.issue=6&amp;rft.au=Lemaire+L%2C%0A+++++Fournier+J%2C+Ponthus+C%2C+Le+Fur+Y%2C+Confort-Gouny+S%2C+Vion-Dury+J%2C+Keane+P%2C+Cozzone+P&amp;rft.pages=321-7">&#160;</span></li>
<li id="_note-51"><b><a href="#_ref-51" title="">^</a></b> <cite style="font-style:normal">Zamrini E (2006). "Emerging Drug Therapies for Dementia.". <i>Geriatrics Aging</i> <b>9</b> (2): 107,110-113.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Emerging+Drug+Therapies+for+Dementia.&amp;rft.title=Geriatrics+Aging&amp;rft.jtitle=Geriatrics+Aging&amp;rft.date=2006&amp;rft.volume=9&amp;rft.issue=2&amp;rft.au=Zamrini+E&amp;rft.pages=107%2C110-113">&#160;</span> <a href="http://www.medscape.com/viewarticle/525596_print" class="external autonumber" title="http://www.medscape.com/viewarticle/525596_print" rel="nofollow">[6]</a>.</li>
<li id="_note-52"><b><a href="#_ref-52" title="">^</a></b> <cite style="font-style:normal">Eriksen J, Sagi S, Smith T, Weggen S, Das P, McLendon D, Ozols V, Jessing K, Zavitz K, Koo E, Golde T (2003). "NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 <i>in vivo</i>.". <i>J Clin Invest</i> <b>112</b> (3): 440-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12897211" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12897211">PMID 12897211</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=NSAIDs+and+enantiomers+of+flurbiprofen+target+gamma-secretase+and+lower+Abeta+42+%27%27in+vivo%27%27.&amp;rft.title=J+Clin+Invest&amp;rft.jtitle=J+Clin+Invest&amp;rft.date=2003&amp;rft.volume=112&amp;rft.issue=3&amp;rft.au=Eriksen+J%2C+Sagi+S%2C+Smith+T%2C+Weggen+S%2C+Das+P%2C+McLendon+D%2C+Ozols+V%2C%0A+++++++Jessing+K%2C+Zavitz+K%2C+Koo+E%2C+Golde+T&amp;rft.pages=440-9">&#160;</span>.</li>
<li id="_note-53"><b><a href="#_ref-53" title="">^</a></b> <cite style="font-style:normal">Casadesus G, Garrett M, Webber K, Hartzler A, Atwood C, Perry G, Bowen R, Smith M (2006). "The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.". <i>Drugs R D</i> <b>7</b> (3): 187-93. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16752944" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16752944">PMID 16752944</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+estrogen+myth%3A+potential+use+of+gonadotropin-releasing+hormone+agonists+for+the+treatment+of+Alzheimer%27s+disease.&amp;rft.title=Drugs+R+D&amp;rft.jtitle=Drugs+R+D&amp;rft.date=2006&amp;rft.volume=7&amp;rft.issue=3&amp;rft.au=Casadesus+G%2C+Garrett+M%2C+Webber+K%2C+Hartzler+A%2C+Atwood+C%2C+Perry+G%2C+Bowen+R%2C+Smith+M&amp;rft.pages=187-93">&#160;</span>.</li>
<li id="_note-54"><b><a href="#_ref-54" title="">^</a></b> <a href="http://www.alz.org/Resources/TopicIndex/AN1792.asp" class="external text" title="http://www.alz.org/Resources/TopicIndex/AN1792.asp" rel="nofollow">Alzheimer’s Association Fact Sheet: AN-1792 (2006, on ALZ.org)</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../n/o/v/November_6.html" title="November 6">11-06</a>..</li>
<li id="_note-55"><b><a href="#_ref-55" title="">^</a></b> <a href="http://news.bbc.co.uk/2/hi/health/6286689.stm" class="external free" title="http://news.bbc.co.uk/2/hi/health/6286689.stm" rel="nofollow">http://news.bbc.co.uk/2/hi/health/6286689.stm</a></li>
<li id="_note-56"><b><a href="#_ref-56" title="">^</a></b> <cite style="font-style:normal">Landreth G (2006). "PPARgamma agonists as new therapeutic agents for treatment of Alzheimer's disease.". <i>Exp Neurol</i> <b>199</b> (2): 245-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16733054" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16733054">PMID 16733054</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=PPARgamma+agonists+as+new+therapeutic+agents+for+treatment+of+Alzheimer%27s+disease.&amp;rft.title=Exp+Neurol&amp;rft.jtitle=Exp+Neurol&amp;rft.date=2006&amp;rft.volume=199&amp;rft.issue=2&amp;rft.au=Landreth+G&amp;rft.pages=245-8">&#160;</span></li>
<li id="_note-57"><b><a href="#_ref-57" title="">^</a></b> Treating behavioral and psychiatric symptoms. Alzheimer's Association. Accessed Oct. 15, 2006.<a href="http://www.alz.org/Health/Treating/agitation.asp#behavioral" class="external autonumber" title="http://www.alz.org/Health/Treating/agitation.asp#behavioral" rel="nofollow">[7]</a></li>
<li id="_note-58"><b><a href="#_ref-58" title="">^</a></b> <cite style="font-style:normal">Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A. (2004). "Visual contrast enhances food and liquid intake in advanced Alzheimer's disease". <i>Clin Nutr</i> <b>23</b> (4): 533-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15297089" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15297089">PMID 15297089</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Visual+contrast+enhances+food+and+liquid+intake+in+advanced+Alzheimer%27s+disease&amp;rft.title=Clin+Nutr&amp;rft.jtitle=Clin+Nutr&amp;rft.date=2004&amp;rft.volume=23&amp;rft.issue=4&amp;rft.au=Dunne+TE%2C+Neargarder+SA%2C+Cipolloni+PB%2C+Cronin-Golomb+A.&amp;rft.pages=533-8">&#160;</span></li>
<li id="_note-59"><b><a href="#_ref-59" title="">^</a></b> <cite style="font-style:normal">Sloane P, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S. "The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.". <i>Annu Rev Public Health</i> <b>23</b>: 213-31. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11910061" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11910061">PMID 11910061</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+public+health+impact+of+Alzheimer%27s+disease%2C+2000-2050%3A+potential+implication+of+treatment+advances.&amp;rft.title=Annu+Rev+Public+Health&amp;rft.jtitle=Annu+Rev+Public+Health&amp;rft.volume=23&amp;rft.au=Sloane+P%2C+Zimmerman+S%2C+Suchindran+C%2C+Reed+P%2C+Wang+L%2C+Boustani+M%2C+Sudha+S&amp;rft.pages=213-31">&#160;</span></li>
<li id="_note-60"><b><a href="#_ref-60" title="">^</a></b> <cite style="font-style:normal">"The MetLife Study of Alzheimer’s Disease: The Caregiving Experience". <i>MetLife Mature Market Institute ®</i> (August 2006).</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+MetLife+Study+of+Alzheimer%E2%80%99s+Disease%3A+The+Caregiving+Experience&amp;rft.title=MetLife+Mature+Market+Institute+%C2%AE&amp;rft.jtitle=MetLife+Mature+Market+Institute+%C2%AE&amp;rft.issue=August+2006">&#160;</span> <a href="http://www.metlife.com/WPSAssets/14050063731156260663V1FAlzheimerCaregivingExperience.pdf" class="external autonumber" title="http://www.metlife.com/WPSAssets/14050063731156260663V1FAlzheimerCaregivingExperience.pdf" rel="nofollow">[8]</a></li>
<li id="_note-61"><b><a href="#_ref-61" title="">^</a></b> <a href="http://www.cdc.gov/nchs/fastats/alzheimr.htm" class="external text" title="http://www.cdc.gov/nchs/fastats/alzheimr.htm" rel="nofollow">Faststats – Alzheimer's Disease</a> National Center for Health Statistics</li>
<li id="_note-62"><b><a href="#_ref-62" title="">^</a></b> <a href="http://www.aging-institute.org/about/annualrp.html" class="external text" title="http://www.aging-institute.org/about/annualrp.html" rel="nofollow">Alzheimer's Drug Discovery Foundation 2005 Annual Report</a></li>
<li id="_note-63"><b><a href="#_ref-63" title="">^</a></b> <a href="http://www.alz.co.uk/research/statistics.html" class="external text" title="http://www.alz.co.uk/research/statistics.html" rel="nofollow">Statistics - Alzheimer's Disease International</a></li>
<li id="_note-AboutAD">^ <a href="#_ref-AboutAD_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-AboutAD_1" title=""><sup><i><b>b</b></i></sup></a> <a href="http://www.alz.org/AboutAD/statistics.asp" class="external text" title="http://www.alz.org/AboutAD/statistics.asp" rel="nofollow">Alzheimer's Facts and Figures</a> Alzheimer's Association</li>
<li id="_note-64"><b><a href="#_ref-64" title="">^</a></b> <a href="http://w3.uokhsc.edu/pathology/DeptLabs/diagnostic_center_for_alzheimer.htm" class="external text" title="http://w3.uokhsc.edu/pathology/DeptLabs/diagnostic_center_for_alzheimer.htm" rel="nofollow">Diagnostic Center for Alzheimer's Disease</a></li>
<li id="_note-65"><b><a href="#_ref-65" title="">^</a></b> <cite class="book" style="font-style:normal">Shenk, David (2003). <i>The Forgetting Alzheimer’s: Portrait of an Epidemic</i>. New York: Anchor Books. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-385-49838-1</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Forgetting++Alzheimer%E2%80%99s%3A++Portrait+of+an+Epidemic&amp;rft.title=The+Forgetting++Alzheimer%E2%80%99s%3A++Portrait+of+an+Epidemic&amp;rft.aulast=Shenk&amp;rft.aufirst=David&amp;rft.date=2003&amp;rft.pub=Anchor+Books&amp;rft.place=New+York">&#160;</span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/z/Alzheimer%27s_disease.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<div class="infobox sisterproject">
<div class="floatleft"><span><a href="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" class="image" title=""><img src="../../../upload/thumb/4/4a/Commons-logo.svg/50px-Commons-logo.svg.png" alt="" width="50" height="67" longdesc="../../../c/o/m/Image%7ECommons-logo.svg_62a0.html" /></a></span></div>
<div style="margin-left: 60px;"><a href="../../../w/i/k/Wikimedia_Commons_7b57.html" title="Wikimedia Commons">Wikimedia Commons</a> has media related to:
<div style="margin-left: 10px;"><i><b><a href="http://commons.wikimedia.org/wiki/Category:Alzheimer%27s_disease" class="extiw" title="commons:Category:Alzheimer's_disease">Alzheimer's disease</a></b></i></div>
</div>
</div>
<ul>
<li><a href="http://www.alzheimers.org.uk" class="external text" title="http://www.alzheimers.org.uk" rel="nofollow">Alzheimers Society</a> - Alzheimers Society</li>
<li><a href="http://www.alzinfo.org" class="external text" title="http://www.alzinfo.org" rel="nofollow">Alzheimer's Research Foundation</a> - The Fisher Center For Alzheimer's Research Foundation. Nobel Prize Winning Alzheimer's Disease Research.</li>
<li><a href="http://www.alzforum.org" class="external text" title="http://www.alzforum.org" rel="nofollow">Alzheimer's Research Forum</a> - A website intended to provide information to and foster collaboration among scientists and physicians conducting research on Alzheimer's. Features debates between and article annotations by many top Alzheimer's researchers</li>
<li><a href="http://www.nia.nih.gov/alzheimers" class="external text" title="http://www.nia.nih.gov/alzheimers" rel="nofollow">National Institute on Aging</a> - Substantial website by a division of the U.S. National Institutes of Health with links to information about ongoing clinical studies</li>
<li><a href="http://www.alzheimersdementiainfo.com" class="external text" title="http://www.alzheimersdementiainfo.com" rel="nofollow">Information and Resources Regarding Alzheimer's Disease and Dementia</a></li>
<li><a href="http://www.nia.nih.gov/Alzheimers/ResearchInformation/ResearchCenters" class="external text" title="http://www.nia.nih.gov/Alzheimers/ResearchInformation/ResearchCenters" rel="nofollow">Alzheimer's Disease Research Centers</a> - Links to each of the NIH-funded centers of excellence for Alzheimer's disease located at academic medical centers scattered throughout the U.S.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=104300" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=104300" rel="nofollow">OMIM</a> - Running, highly technical synopsis of research on Alzheimer's disease maintained by the NIH</li>
<li><a href="http://www.alznews.com/" class="external text" title="http://www.alznews.com/" rel="nofollow">Alzheimer's Daily Newsletter</a> - Provides links to news on the social, political, and scientific issues around Alzheimer's.</li>
<li><a href="http://www.j-alz.com" class="external text" title="http://www.j-alz.com" rel="nofollow">Journal of Alzheimer's Disease</a> - Subscription required for full text</li>
<li><a href="http://www.emedicinehealth.com/articles/39500-1.asp" class="external text" title="http://www.emedicinehealth.com/articles/39500-1.asp" rel="nofollow">eMedicine</a> - Well-organized article on Alzheimer's</li>
<li><a href="http://med.uni-muenchen.de/haass" class="external text" title="http://med.uni-muenchen.de/haass" rel="nofollow">Ludwig-Maximilians-University Munich</a> - Laboratory for Neurodegenerative Disease Research, Prof. Dr. Christian Haass</li>
<li><a href="http://www.alzheimers.org.uk/bournemouth" class="external free" title="http://www.alzheimers.org.uk/bournemouth" rel="nofollow">http://www.alzheimers.org.uk/bournemouth</a> - Bournemouth Alzheimers Society<span id="interwiki-ro-fa"></span></li>
</ul>

<!-- 
Pre-expand include size: 380419 bytes
Post-expand include size: 150636 bytes
Template argument size: 113866 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/l/z/Alzheimer%27s_disease.html">http://en.wikipedia.org../../../a/l/z/Alzheimer%27s_disease.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../a/l/z/Category%7EAlzheimer%27s_disease_c69a.html" title="Category:Alzheimer's disease">Alzheimer's disease</a></span> | <span dir='ltr'><a href="../../../n/e/u/Category%7ENeurology_7728.html" title="Category:Neurology">Neurology</a></span> | <span dir='ltr'><a href="../../../u/n/s/Category%7EUnsolved_problems_in_neuroscience_b233.html" title="Category:Unsolved problems in neuroscience">Unsolved problems in neuroscience</a></span> | <span dir='ltr'><a href="../../../p/a/t/Category%7EPathology_c83f.html" title="Category:Pathology">Pathology</a></span> | <span dir='ltr'><a href="../../../e/p/o/Category%7EEponymous_medical_terms_b3ba.html" title="Category:Eponymous medical terms">Eponymous medical terms</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/l/z/Alzheimer%27s_disease.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/l/z/Talk%7EAlzheimer%27s_disease_e367.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Alzheimer%27s_disease">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../af/a/l/z/Alzheimer_se_siekte.html">Afrikaans</a>
	      </li>
	      	      <li>
	      <a href="../../../../ar/%D8%A3/%D9%84/%D8%B2/%D8%A3%D9%84%D8%B2%D9%87%D8%A7%D9%8A%D9%85%D8%B1.html">العربية</a>
	      </li>
	      	      <li>
	      <a href="../../../../ast/a/l/z/Alzheimer.html">Asturianu</a>
	      </li>
	      	      <li>
	      <a href="../../../../bg/%D0%B1/%D0%BE/%D0%BB/%D0%91%D0%BE%D0%BB%D0%B5%D1%81%D1%82_%D0%BD%D0%B0_%D0%90%D0%BB%D1%86%D1%85%D0%B0%D0%B9%D0%BC%D0%B5%D1%80_5159.html">Български</a>
	      </li>
	      	      <li>
	      <a href="../../../../ca/m/a/l/Malaltia_d%27Alzheimer_fc55.html">Català</a>
	      </li>
	      	      <li>
	      <a href="../../../../cs/a/l/z/Alzheimerova_choroba.html">Česky</a>
	      </li>
	      	      <li>
	      <a href="../../../../da/a/l/z/Alzheimers_sygdom.html">Dansk</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/l/z/Alzheimer-Krankheit_ab61.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/e/n/f/Enfermedad_de_Alzheimer_6e7c.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../eo/a/l/c/Alchajmero.html">Esperanto</a>
	      </li>
	      	      <li>
	      <a href="../../../../fa/%D8%A2/%D9%84/%D8%B2/%D8%A2%D9%84%D8%B2%D8%A7%DB%8C%D9%85%D8%B1.html">فارسی</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/m/a/l/Maladie_d%27Alzheimer_2b38.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../gl/a/l/z/Alzheimer.html">Galego</a>
	      </li>
	      	      <li>
	      <a href="../../../../ko/%EC%95%8C/%EC%B8%A0/%ED%95%98/%EC%95%8C%EC%B8%A0%ED%95%98%EC%9D%B4%EB%A8%B8%EB%B3%91.html">한국어</a>
	      </li>
	      	      <li>
	      <a href="../../../../hr/a/l/z/Alzheimerova_bolest.html">Hrvatski</a>
	      </li>
	      	      <li>
	      <a href="../../../../id/a/l/z/Alzheimer.html">Bahasa Indonesia</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/m/o/r/Morbo_di_Alzheimer_d180.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../he/%D7%90/%D7%9C/%D7%A6/%D7%90%D7%9C%D7%A6%D7%94%D7%99%D7%99%D7%9E%D7%A8.html">עברית</a>
	      </li>
	      	      <li>
	      <a href="../../../../lb/a/l/z/Alzheimer.html">Lëtzebuergesch</a>
	      </li>
	      	      <li>
	      <a href="../../../../lt/a/l/c/Alcheimerio_liga.html">Lietuvių</a>
	      </li>
	      	      <li>
	      <a href="../../../../hu/a/l/z/Alzheimer-k%C3%B3r.html">Magyar</a>
	      </li>
	      	      <li>
	      <a href="../../../../ms/a/l/z/Alzheimer.html">Bahasa Melayu</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/z/i/e/Ziekte_van_Alzheimer_295b.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E3%82%A2/%E3%83%AB/%E3%83%84/%E3%82%A2%E3%83%AB%E3%83%84%E3%83%8F%E3%82%A4%E3%83%9E%E3%83%BC%E5%9E%8B%E7%97%B4%E5%91%86.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/l/z/Alzheimers_sykdom.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/c/h/o/Choroba_Alzheimera_cc30.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/m/a/l/Mal_de_Alzheimer_ca54.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ro/b/o/a/Boala_Alzheimer_8341.html">Română</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B1/%D0%BE/%D0%BB/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%90%D0%BB%D1%8C%D1%86%D0%B3%D0%B5%D0%B9%D0%BC%D0%B5%D1%80%D0%B0_cdca.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../simple/a/l/z/Alzheimer%27s_disease.html">Simple English</a>
	      </li>
	      	      <li>
	      <a href="../../../../sk/a/l/z/Alzheimerova_choroba.html">Slovenčina</a>
	      </li>
	      	      <li>
	      <a href="../../../../sr/%D0%B0/%D0%BB/%D1%86/%D0%90%D0%BB%D1%86%D1%85%D0%B0%D1%98%D0%BC%D0%B5%D1%80%D0%BE%D0%B2%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82.html">Српски / Srpski</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/l/z/Alzheimerin_tauti.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/l/z/Alzheimers_sjukdom.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../tr/a/l/z/Alzheimer_hastal%C4%B1%C4%9F%C4%B1.html">Türkçe</a>
	      </li>
	      	      <li>
	      <a href="../../../../uk/%D1%85/%D0%B2/%D0%BE/%D0%A5%D0%B2%D0%BE%D1%80%D0%BE%D0%B1%D0%B0_%D0%90%D0%BB%D1%8C%D1%86%D0%B3%D0%B0%D0%B9%D0%BC%D0%B5%D1%80%D0%B0_fa31.html">Українська</a>
	      </li>
	      	      <li>
	      <a href="../../../../yi/%D7%90/%D7%9C/%D7%98/%D7%90%D7%9C%D7%98%D7%A1%D7%94%D7%99%D7%99%D7%9E%D7%A2%D7%A8%D7%A1.html">ייִדיש</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E9%98%BF/%E5%85%B9/%E6%B5%B7/%E9%98%BF%E5%85%B9%E6%B5%B7%E9%BB%98%E7%97%85.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 02:27, 30 March 2007 by Wikipedia user Jeffrey O. Gustafson. Based on work by Wikipedia user(s) Lary Walker, Mike1thinks, <a href="../../../g/a/r/User%7EGaras_3860.html" title="User:Garas">Garas</a>, <a href="../../../k/a/b/User%7EKablammo_6970.html" title="User:Kablammo">Kablammo</a>, <a href="../../../c/a/n/User%7ECan%27t_sleep%2C_clown_will_eat_me_7058.html" title="User:Can't sleep, clown will eat me">Can't sleep, clown will eat me</a>, <a href="../../../w/k/_/User%7EWk_muriithi_6a20.html" title="User:Wk muriithi">Wk muriithi</a>, <a href="../../../e/d/g/User%7EEdgar181_7e9b.html" title="User:Edgar181">Edgar181</a>, <a href="../../../b/o/b/User%7EBobo192_c260.html" title="User:Bobo192">Bobo192</a>, <a href="../../../b/r/i/User%7EBrianGV_989a.html" title="User:BrianGV">BrianGV</a>, <a href="../../../k/e/k/User%7EKek4la_6baf.html" title="User:Kek4la">Kek4la</a>, <a href="../../../m/a/r/User%7EMartinBot_3f64.html" title="User:MartinBot">MartinBot</a>, <a href="../../../m/a/t/User%7EMatticus78_7ff9.html" title="User:Matticus78">Matticus78</a>, <a href="../../../n/u/n/User%7ENunquam_Dormio_ecde.html" title="User:Nunquam Dormio">Nunquam Dormio</a>, <a href="../../../r/a/v/User%7ERavedave_48c1.html" title="User:Ravedave">Ravedave</a>, <a href="../../../n/a/c/User%7ENaconkantari_d810.html" title="User:Naconkantari">Naconkantari</a>, <a href="../../../d/b/z/User%7EDbzsamuele_5e1c.html" title="User:Dbzsamuele">Dbzsamuele</a>, <a href="../../../t/r/e/User%7ETregonsee_a823.html" title="User:Tregonsee">Tregonsee</a>, <a href="../../../f/l/y/User%7EFlyguy649_8ae4.html" title="User:Flyguy649">Flyguy649</a>, <a href="../../../c/i/r/User%7ECIreland_090d.html" title="User:CIreland">CIreland</a>, Talk2max, <a href="../../../w/i/m/User%7EWimt_5387.html" title="User:Wimt">Wimt</a>, <a href="../../../w/_/g/User%7EW_guice_dd47.html" title="User:W guice">W guice</a>, <a href="../../../w/o/u/User%7EWouterstomp_b006.html" title="User:Wouterstomp">Wouterstomp</a>, <a href="../../../d/e/l/User%7EDeli_nk_ed07.html" title="User:Deli nk">Deli nk</a>, <a href="../../../s/e/l/User%7ESelket_adc6.html" title="User:Selket">Selket</a>, <a href="../../../j/o/n/User%7EJonathan_Drain_9ea0.html" title="User:Jonathan Drain">Jonathan Drain</a>, <a href="../../../v/e/i/User%7EVeinor_0082.html" title="User:Veinor">Veinor</a>, <a href="../../../l/e/a/User%7ELeafyplant_05ff.html" title="User:Leafyplant">Leafyplant</a>, <a href="../../../j/u/s/User%7EJustin_Eiler_f9c0.html" title="User:Justin Eiler">Justin Eiler</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../g/i/f/User%7EGiftlite_9506.html" title="User:Giftlite">Giftlite</a>, <a href="../../../k/i/t/User%7EKittybrewster_2ff5.html" title="User:Kittybrewster">Kittybrewster</a>, <a href="../../../p/a/k/User%7EPAK_Man_460f.html" title="User:PAK Man">PAK Man</a>, <a href="../../../s/c/h/User%7ESchmiteye_ef5b.html" title="User:Schmiteye">Schmiteye</a>, Drterman, Micheal tyler, <a href="../../../m/o/n/User%7EMontco_3514.html" title="User:Montco">Montco</a>, <a href="../../../b/o/t/User%7EBot-Schafter_1a19.html" title="User:Bot-Schafter">Bot-Schafter</a>, Send513, <a href="../../../c/h/r/User%7EChris_73_2ea7.html" title="User:Chris 73">Chris 73</a>, <a href="../../../s/p/u/User%7ESpuriousQ_693d.html" title="User:SpuriousQ">SpuriousQ</a>, <a href="../../../r/i/c/User%7ERichAromas_ad9d.html" title="User:RichAromas">RichAromas</a>, Cloudzor, <a href="../../../a/k/s/User%7EAksi_great_bb76.html" title="User:Aksi great">Aksi great</a>, Charlesbrowne, Kim99, <a href="../../../c/a/e/User%7ECaesarjbsquitti_7f8e.html" title="User:Caesarjbsquitti">Caesarjbsquitti</a>, <a href="../../../s/i/l/User%7ESilverhand_a04b.html" title="User:Silverhand">Silverhand</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../c/h/r/User%7EChrispounds_885a.html" title="User:Chrispounds">Chrispounds</a>, <a href="../../../a/n/t/User%7EAntandrus_5ef3.html" title="User:Antandrus">Antandrus</a>, <a href="../../../a/l/p/User%7EAlphachimp_1adb.html" title="User:Alphachimp">Alphachimp</a>, <a href="../../../w/a/l/User%7EWalton_monarchist89_24d9.html" title="User:Walton monarchist89">Walton monarchist89</a>, <a href="../../../w/r/i/User%7EWrittenonsand_3868.html" title="User:Writtenonsand">Writtenonsand</a>, <a href="../../../j/w/s/User%7EJWSchmidt_1173.html" title="User:JWSchmidt">JWSchmidt</a>, <a href="../../../d/e/l/User%7EDelirium_b0dc.html" title="User:Delirium">Delirium</a>, Fishercenter, Dirk666, <a href="../../../e/d/c/User%7EEdcolins_06ae.html" title="User:Edcolins">Edcolins</a>, Philoprof, <a href="../../../i/p/e/User%7EIpeltan_2363.html" title="User:Ipeltan">Ipeltan</a>, <a href="../../../y/a/m/User%7EYamaguchi%E5%85%88%E7%94%9F_6995.html" title="User:Yamaguchi先生">Yamaguchi先生</a>, <a href="../../../i/m/m/User%7EImmanuel_Giel_f479.html" title="User:Immanuel Giel">Immanuel Giel</a>, <a href="../../../a/l/i/User%7EAlison_304c.html" title="User:Alison">Alison</a>, Lostart, <a href="../../../s/i/r/User%7ESir_Nicholas_de_Mimsy-Porpington_81f8.html" title="User:Sir Nicholas de Mimsy-Porpington">Sir Nicholas de Mimsy-Porpington</a>, <a href="../../../c/h/a/User%7EChaosNil_7556.html" title="User:ChaosNil">ChaosNil</a>, Tony lion, Cazzee, <a href="../../../r/h/e/User%7ERhetth_506d.html" title="User:Rhetth">Rhetth</a>, <a href="../../../h/u/r/User%7EHurmata_87b9.html" title="User:Hurmata">Hurmata</a>, <a href="../../../p/a/r/User%7EParker007_4a88.html" title="User:Parker007">Parker007</a>, Slicky, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, <a href="../../../j/o/n/User%7EJones2_70b8.html" title="User:Jones2">Jones2</a>, <a href="../../../j/c/u/User%7EJcuk_0c1b.html" title="User:Jcuk">Jcuk</a>, Smudley, <a href="../../../c/a/n/User%7ECanadian-Bacon_27f4.html" title="User:Canadian-Bacon">Canadian-Bacon</a>, Cubetriangle, <a href="../../../i/p/s/User%7EIpso2_d1da.html" title="User:Ipso2">Ipso2</a>, <a href="../../../b/i/g/User%7EBigturtle_52ef.html" title="User:Bigturtle">Bigturtle</a>, <a href="../../../t/h/e/User%7ETheEgyptian_df44.html" title="User:TheEgyptian">TheEgyptian</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, <a href="../../../j/r/h/User%7EJrhoadley_4a54.html" title="User:Jrhoadley">Jrhoadley</a>, Boonukem, <a href="../../../s/b/h/User%7ESbharris_26ab.html" title="User:Sbharris">Sbharris</a>, <a href="../../../i/g/o/User%7EIgoruha_c8f6.html" title="User:Igoruha">Igoruha</a>, <a href="../../../s/h/o/User%7EShoessss_80c5.html" title="User:Shoessss">Shoessss</a>, Psiguy, Paulomatsui, Nick0nick005, <a href="../../../w/l/u/User%7EWLU_ad34.html" title="User:WLU">WLU</a>, Bob727bob727bob, <a href="../../../d/r/i/User%7EDrini_e6be.html" title="User:Drini">Drini</a>, CaliforniaLyme, <a href="../../../g/u/n/User%7EGungadin_4999.html" title="User:Gungadin">Gungadin</a>, Eswarner, <a href="../../../b/r/a/User%7EBrandmeister_dd66.html" title="User:Brandmeister">Brandmeister</a>, UISKuwait, <a href="../../../c/a/l/User%7ECalltech_9c69.html" title="User:Calltech">Calltech</a>, <a href="../../../r/u/m/User%7ERumpelstiltskin223_6de5.html" title="User:Rumpelstiltskin223">Rumpelstiltskin223</a>, Hawksj, <a href="../../../v/o/l/User%7EVoldemortuet_673c.html" title="User:Voldemortuet">Voldemortuet</a>, <a href="../../../j/a/n/User%7EJAnDbot_5c44.html" title="User:JAnDbot">JAnDbot</a>, <a href="../../../d/o/r/User%7EDorganBot_b7c4.html" title="User:DorganBot">DorganBot</a>, <a href="../../../e/s/c/User%7EEscarbot_9d83.html" title="User:Escarbot">Escarbot</a>, <a href="../../../n/o/r/User%7ENorVegan_16e6.html" title="User:NorVegan">NorVegan</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, Vikrammat, <a href="../../../s/n/o/User%7ESnowmanradio_64ad.html" title="User:Snowmanradio">Snowmanradio</a>, <a href="../../../d/e/v/User%7EDevilgate_bca3.html" title="User:Devilgate">Devilgate</a>, Anukar, <a href="../../../p/h/i/User%7EPhidauex_18a7.html" title="User:Phidauex">Phidauex</a>, <a href="../../../w/i/k/User%7EWikiman_a8c7.html" title="User:Wikiman">Wikiman</a>, <a href="../../../p/v/o/User%7EPvosta_2ba4.html" title="User:Pvosta">Pvosta</a>, <a href="../../../r/i/c/User%7ERiccardobot_1f37.html" title="User:Riccardobot">Riccardobot</a>, <a href="../../../m/e/r/User%7EMerope_5bcb.html" title="User:Merope">Merope</a>, <a href="../../../j/o/n/User%7EJonHarder_ef53.html" title="User:JonHarder">JonHarder</a>, <a href="../../../m/p/o/User%7EMporter_1d80.html" title="User:Mporter">Mporter</a>, <a href="../../../w/h/y/User%7EWhy_My_Fleece__2721.html" title="User:Why My Fleece?">Why My Fleece?</a>, <a href="../../../h/a/g/User%7EHagerman_2dd6.html" title="User:Hagerman">Hagerman</a>, <a href="../../../b/u/b/User%7EBubba_hotep_ee80.html" title="User:Bubba hotep">Bubba hotep</a>, <a href="../../../c/o/p/User%7ECopperKettle_9495.html" title="User:CopperKettle">CopperKettle</a>, <a href="../../../p/n/k/User%7EPnkrockr_70a2.html" title="User:Pnkrockr">Pnkrockr</a>, <a href="../../../p/a/w/User%7EPawl_Kennedy_15cd.html" title="User:Pawl Kennedy">Pawl Kennedy</a>, <a href="../../../r/y/a/User%7ERyanjo_ef4c.html" title="User:Ryanjo">Ryanjo</a>, <a href="../../../w/i/k/User%7EWikid77_2576.html" title="User:Wikid77">Wikid77</a>, <a href="../../../d/u/k/User%7EDukemeiser_16f3.html" title="User:Dukemeiser">Dukemeiser</a>, <a href="../../../m/t/s/User%7EMTSbot_3c20.html" title="User:MTSbot">MTSbot</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../a/n/o/User%7EAnoncow_bdd4.html" title="User:Anoncow">Anoncow</a>, Mergneed, <a href="../../../s/a/m/User%7ESamsara_87dc.html" title="User:Samsara">Samsara</a>, Matt Lewis, <a href="../../../t/l/m/User%7ETlmclain_4c55.html" title="User:Tlmclain">Tlmclain</a>, <a href="../../../r/e/e/User%7ERees11_32a8.html" title="User:Rees11">Rees11</a>, Menonsneha, Brainyiscool, <a href="../../../v/a/o/User%7EVaoverland_3ef2.html" title="User:Vaoverland">Vaoverland</a>, <a href="../../../n/i/c/User%7ENick_55c2.html" title="User:Nick">Nick</a>, <a href="../../../p/h/i/User%7EPhil_Nesbitt_7905.html" title="User:Phil Nesbitt">Phil Nesbitt</a>, <a href="../../../o/p/a/User%7EOpabinia_regalis_4201.html" title="User:Opabinia regalis">Opabinia regalis</a>, <a href="../../../n/u/m/User%7ENumbo3_f4e9.html" title="User:Numbo3">Numbo3</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, Bizflyer, <a href="../../../h/i/g/User%7EHighInBC_48ba.html" title="User:HighInBC">HighInBC</a>, <a href="../../../m/b/1/User%7EMb1000_3f7c.html" title="User:Mb1000">Mb1000</a>, Jnx, <a href="../../../p/s/i/User%7EPsi-kat_e01a.html" title="User:Psi-kat">Psi-kat</a>, <a href="../../../q/u/e/User%7EQuendus_12a6.html" title="User:Quendus">Quendus</a>, Steelers132, By97aa, <a href="../../../s/a/s/User%7ESashatoBot_1555.html" title="User:SashatoBot">SashatoBot</a>, <a href="../../../e/4/0/User%7EE4043_a166.html" title="User:E4043">E4043</a>, Rdfrds, <a href="../../../s/h/a/User%7EShanes_8450.html" title="User:Shanes">Shanes</a>, <a href="../../../g/o/g/User%7EGogo_Dodo_6e56.html" title="User:Gogo Dodo">Gogo Dodo</a>, <a href="../../../m/r/b/User%7EMrbluesky_2d3f.html" title="User:Mrbluesky">Mrbluesky</a>, <a href="../../../y/y/l/User%7EYyll_75f5.html" title="User:Yyll">Yyll</a>, <a href="../../../l/o/l/User%7ELOL_deab.html" title="User:LOL">LOL</a>, <a href="../../../o/h/n/User%7EOhnoitsjamie_fc14.html" title="User:Ohnoitsjamie">Ohnoitsjamie</a>, Ayotte, Jsmjsm, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../d/o/g/User%7EDogface_68d5.html" title="User:Dogface">Dogface</a>, <a href="../../../b/o/t/User%7EBota47_16c2.html" title="User:Bota47">Bota47</a>, <a href="../../../d/l/o/User%7EDlohcierekim_440b.html" title="User:Dlohcierekim">Dlohcierekim</a>, <a href="../../../l/u/n/User%7ELuna_Santin_1cab.html" title="User:Luna Santin">Luna Santin</a>, Randomloser, <a href="../../../w/i/g/User%7EWigren_fcdd.html" title="User:Wigren">Wigren</a>, <a href="../../../r/o/r/User%7ERory096_e5c4.html" title="User:Rory096">Rory096</a>, <a href="../../../t/d/n/User%7ETDN169_f8e2.html" title="User:TDN169">TDN169</a>, Griffnyc, <a href="../../../i/a/n/User%7EIan_Goddard_d907.html" title="User:Ian Goddard">Ian Goddard</a>, <a href="../../../h/a/r/User%7EHarryboyles_b16b.html" title="User:Harryboyles">Harryboyles</a>, <a href="../../../m/i/t/User%7EMithridates_47c8.html" title="User:Mithridates">Mithridates</a>, <a href="../../../m/i/k/User%7EMike_Rosoft_96ed.html" title="User:Mike Rosoft">Mike Rosoft</a>, <a href="../../../d/a/k/User%7EDaksya_47f3.html" title="User:Daksya">Daksya</a>, <a href="../../../a/l/_/User%7EAl_Rasheed_4095.html" title="User:Al Rasheed">Al Rasheed</a>, <a href="../../../k/o/n/User%7EKonman72_ac5b.html" title="User:Konman72">Konman72</a>, Cariaso, Paolo De Silva, Npang, Kibiusa, <a href="../../../h/_/p/User%7EH_Padleckas_0cae.html" title="User:H Padleckas">H Padleckas</a>, <a href="../../../m/i/c/User%7EMichele123_c592.html" title="User:Michele123">Michele123</a>, <a href="../../../b/r/e/User%7EBrewhaha%40edmc.net_dd38.html" title="User:Brewhaha@edmc.net">Brewhaha@edmc.net</a>, Davidmwilson, <a href="../../../m/a/t/User%7EMatthuxtable_ab42.html" title="User:Matthuxtable">Matthuxtable</a>, <a href="../../../s/t/i/User%7ESticks_db_8193.html" title="User:Sticks db">Sticks db</a>, <a href="../../../p/r/e/User%7EPretzelpaws_934f.html" title="User:Pretzelpaws">Pretzelpaws</a>, <a href="../../../m/r/m/User%7EMrMarmite_7b5f.html" title="User:MrMarmite">MrMarmite</a>, <a href="../../../f/n/i/User%7EFnielsen_77f8.html" title="User:Fnielsen">Fnielsen</a>, Asgeir.enersen, <a href="../../../n/m/g/User%7ENmg20_469b.html" title="User:Nmg20">Nmg20</a>, Jaranda, <a href="../../../r/e/b/User%7ERebelguys2_63db.html" title="User:Rebelguys2">Rebelguys2</a>, <a href="../../../l/i/p/User%7ELipothymia_8fdd.html" title="User:Lipothymia">Lipothymia</a>, <a href="../../../g/w/e/User%7EGwernol_c4bf.html" title="User:Gwernol">Gwernol</a>, CNicol, <a href="../../../f/e/e/User%7EFeedmecereal_03ab.html" title="User:Feedmecereal">Feedmecereal</a>, <a href="../../../b/e/g/User%7EBeginning_2e6d.html" title="User:Beginning">Beginning</a>, <a href="../../../g/e/n/User%7EGeneral_Tojo_-_still_here_%21_51d7.html" title="User:General Tojo - still here !">General Tojo - still here !</a>, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, <a href="../../../b/r/o/User%7EBrockwell_326a.html" title="User:Brockwell">Brockwell</a>, <a href="../../../a/t/t/User%7EAtterton_6df7.html" title="User:Atterton">Atterton</a>, <a href="../../../z/a/m/User%7EZamalek_86f8.html" title="User:Zamalek">Zamalek</a>, <a href="../../../k/w/e/User%7EKwekubo_9160.html" title="User:Kwekubo">Kwekubo</a>, <a href="../../../m/e/s/User%7EMestre_0964.html" title="User:Mestre">Mestre</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, <a href="../../../s/t/e/User%7EStevenfruitsmaak_e31a.html" title="User:Stevenfruitsmaak">Stevenfruitsmaak</a>, <a href="../../../i/s/t/User%7EIstvanWolf_aaa4.html" title="User:IstvanWolf">IstvanWolf</a>, Salgueiro, <a href="../../../g/r/a/User%7EGraemeL_c5a8.html" title="User:GraemeL">GraemeL</a>, <a href="../../../j/o/h/User%7EJohn254_98f8.html" title="User:John254">John254</a>, Spesaeterna, Mujib, <a href="../../../w/i/n/User%7EWinhunter_d2c4.html" title="User:Winhunter">Winhunter</a>, <a href="../../../r/o/y/User%7ERoyBoy_492a.html" title="User:RoyBoy">RoyBoy</a>, <a href="../../../j/a/n/User%7EJanviermichelle_ce95.html" title="User:Janviermichelle">Janviermichelle</a>, <a href="../../../m/o/r/User%7EMoraSique_d7e9.html" title="User:MoraSique">MoraSique</a>, <a href="../../../a/n/l/User%7EAnlace_5bdb.html" title="User:Anlace">Anlace</a>, Twohairs, <a href="../../../d/j/_/User%7EDJ_Clayworth_c4dc.html" title="User:DJ Clayworth">DJ Clayworth</a>, <a href="../../../r/s/m/User%7ERsm99833_7388.html" title="User:Rsm99833">Rsm99833</a>, <a href="../../../f/l/y/User%7EFlydpnkrtn_68fb.html" title="User:Flydpnkrtn">Flydpnkrtn</a>, <a href="../../../k/a/y/User%7EKayag_8a8a.html" title="User:Kayag">Kayag</a>, <a href="../../../o/m/i/User%7EOmicronpersei8_71da.html" title="User:Omicronpersei8">Omicronpersei8</a>, <a href="../../../t/a/w/User%7ETawkerbot2_313a.html" title="User:Tawkerbot2">Tawkerbot2</a>, Gokkers, <a href="../../../e/s/p/User%7EEspresso_Addict_7f98.html" title="User:Espresso Addict">Espresso Addict</a>, <a href="../../../w/e/g/User%7EWeggeBot_7120.html" title="User:WeggeBot">WeggeBot</a>, <a href="../../../c/a/n/User%7ECanadian_Paul_56ec.html" title="User:Canadian Paul">Canadian Paul</a>, <a href="../../../t/b/a/User%7ETBadger_d089.html" title="User:TBadger">TBadger</a>, <a href="../../../t/a/w/User%7ETawker_141a.html" title="User:Tawker">Tawker</a>, <a href="../../../k/h/o/User%7EKhoikhoi_b62f.html" title="User:Khoikhoi">Khoikhoi</a>, Vivek333, <a href="../../../b/e/t/User%7EBetacommand_e660.html" title="User:Betacommand">Betacommand</a>, <a href="../../../k/a/i/User%7EKaisershatner_51b9.html" title="User:Kaisershatner">Kaisershatner</a>, <a href="../../../s/h/a/User%7EShandolad_1055.html" title="User:Shandolad">Shandolad</a>, <a href="../../../a/n/g/User%7EAngr_862c.html" title="User:Angr">Angr</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, Aznpride, Xapz, The1anton, <a href="../../../k/y/t/User%7EKythias_f969.html" title="User:Kythias">Kythias</a>, Ve ri tas, <a href="../../../a/r/g/User%7EArgon233_2714.html" title="User:Argon233">Argon233</a>, Xanthoptica, <a href="../../../j/o/a/User%7EJoanneB_e69b.html" title="User:JoanneB">JoanneB</a>, <a href="../../../g/e/n/User%7EGeneral_Tojo_3976.html" title="User:General Tojo">General Tojo</a>, <a href="../../../m/i/k/User%7EMike_Selinker_8b26.html" title="User:Mike Selinker">Mike Selinker</a>, <a href="../../../a/m/i/User%7EAmiDaniel_52f1.html" title="User:AmiDaniel">AmiDaniel</a>, Moonknightus, <a href="../../../t/e/d/User%7ETedE_dbe1.html" title="User:TedE">TedE</a>, <a href="../../../g/u/a/User%7EGuanaco_98c8.html" title="User:Guanaco">Guanaco</a>, <a href="../../../j/a/s/User%7EJASFonseca_3769.html" title="User:JASFonseca">JASFonseca</a>, Omgwtflolbbq, <a href="../../../m/o/n/User%7EMonkeyman_4f4d.html" title="User:Monkeyman">Monkeyman</a>, Matthausia, <a href="../../../c/o/n/User%7ECondem_139c.html" title="User:Condem">Condem</a>, <a href="../../../c/a/r/User%7ECarlwfbird_72bb.html" title="User:Carlwfbird">Carlwfbird</a>, <a href="../../../m/i/d/User%7EMidgley_e5a1.html" title="User:Midgley">Midgley</a>, <a href="../../../r/f/r/User%7ERfrisbie_fdd2.html" title="User:Rfrisbie">Rfrisbie</a>, <a href="../../../c/o/g/User%7ECogpsych_e4d0.html" title="User:Cogpsych">Cogpsych</a>, <a href="../../../b/e/z/User%7EBezapt_9d44.html" title="User:Bezapt">Bezapt</a>, <a href="../../../k/u/r/User%7EKuru_b024.html" title="User:Kuru">Kuru</a>, <a href="../../../b/i/l/User%7EBillG_3090.html" title="User:BillG">BillG</a>, <a href="../../../j/x/b/User%7EJxb311_69a5.html" title="User:Jxb311">Jxb311</a>, <a href="../../../m/i/n/User%7EMinghong_2ceb.html" title="User:Minghong">Minghong</a>, <a href="../../../j/o/s/User%7EJoshbuddy_ab10.html" title="User:Joshbuddy">Joshbuddy</a>, <a href="../../../x/w/u/User%7EXwu_c8a5.html" title="User:Xwu">Xwu</a>, <a href="../../../j/e/r/User%7EJeramieHicks_fd7e.html" title="User:JeramieHicks">JeramieHicks</a>, <a href="../../../h/i/n/User%7EHinotori_3bf9.html" title="User:Hinotori">Hinotori</a>, A314268, Chessmaniac, <a href="../../../c/h/l/User%7EChlewbot_ac63.html" title="User:Chlewbot">Chlewbot</a>, <a href="../../../k/u/n/User%7EKungfuadam_b5d5.html" title="User:Kungfuadam">Kungfuadam</a>, <a href="../../../w/i/k/User%7EWiki_alf_522c.html" title="User:Wiki alf">Wiki alf</a>, <a href="../../../s/t/a/User%7EStaypuftman_3488.html" title="User:Staypuftman">Staypuftman</a>, <a href="../../../j/o/r/User%7EJorvik_a61f.html" title="User:Jorvik">Jorvik</a>, Philips12, <a href="../../../g/l/e/User%7EGlen_Finney_c6cd.html" title="User:Glen Finney">Glen Finney</a>, <a href="../../../b/o/r/User%7EBorgQueen_c70e.html" title="User:BorgQueen">BorgQueen</a>, <a href="../../../b/i/o/User%7EBiopresto_dedd.html" title="User:Biopresto">Biopresto</a>, <a href="../../../e/a/s/User%7EEaster_Monkey_13f5.html" title="User:Easter Monkey">Easter Monkey</a>, <a href="../../../c/h/o/User%7EChobot_0dce.html" title="User:Chobot">Chobot</a>, <a href="../../../s/j/s/User%7ESjsilverman_e938.html" title="User:Sjsilverman">Sjsilverman</a>, <a href="../../../n/e/u/User%7ENeurodoc_4085.html" title="User:Neurodoc">Neurodoc</a>, <a href="../../../t/o/p/User%7ETopaz_8a10.html" title="User:Topaz">Topaz</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../w/i/k/User%7EWikiNewbie_03ba.html" title="User:WikiNewbie">WikiNewbie</a>, PatsyHendren, Fruitbat, <a href="../../../p/m/a/User%7EPMA_64d9.html" title="User:PMA">PMA</a>, <a href="../../../p/h/i/User%7EPhilipO_a77c.html" title="User:PhilipO">PhilipO</a>, FlipOne, <a href="../../../a/e/d/User%7EAED_76b1.html" title="User:AED">AED</a>, David H Braun (1964), <a href="../../../d/a/n/User%7EDanny-w_d1ec.html" title="User:Danny-w">Danny-w</a>, <a href="../../../s/t/e/User%7ESteggall_0275.html" title="User:Steggall">Steggall</a>, <a href="../../../u/n/y/User%7EUnyoyega_ed0f.html" title="User:Unyoyega">Unyoyega</a>, <a href="../../../s/a/l/User%7ESallison_24f1.html" title="User:Sallison">Sallison</a>, <a href="../../../j/o/s/User%7EJossi_3859.html" title="User:Jossi">Jossi</a>, <a href="../../../m/o/n/User%7EMONGO_8e88.html" title="User:MONGO">MONGO</a>, Gladys Swager, <a href="../../../k/e/w/User%7EKewp_9a75.html" title="User:Kewp">Kewp</a>, <a href="../../../n/k/_/User%7ENk_5884.html" title="User:Nk">Nk</a>, <a href="../../../c/a/p/User%7ECapecodeph_330c.html" title="User:Capecodeph">Capecodeph</a>, <a href="../../../c/a/n/User%7ECanderson7_df2b.html" title="User:Canderson7">Canderson7</a>, <a href="../../../r/l/_/User%7ERl_43ae.html" title="User:Rl">Rl</a>, <a href="../../../r/m/s/User%7ERms125a%40hotmail.com_3ce9.html" title="User:Rms125a@hotmail.com">Rms125a@hotmail.com</a>, Mitchellanderson, <a href="../../../k/a/r/User%7EKaras_peter%40yahoo.com_0e2a.html" title="User:Karas peter@yahoo.com">Karas peter@yahoo.com</a>, Milanos, <a href="../../../d/r/y/User%7EDryman_cf3f.html" title="User:Dryman">Dryman</a>, <a href="../../../j/l/a/User%7EJlam4911_3530.html" title="User:Jlam4911">Jlam4911</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../m/r/2E/User%7EMr._Know-It-All_9b88.html" title="User:Mr. Know-It-All">Mr. Know-It-All</a>, <a href="../../../n/e/u/User%7ENeuroscientist_55b6.html" title="User:Neuroscientist">Neuroscientist</a>, <a href="../../../r/e/a/User%7EReadparse_a20e.html" title="User:Readparse">Readparse</a>, <a href="../../../g/u/s/User%7EGusF_3236.html" title="User:GusF">GusF</a>, Sarahndipity, <a href="../../../d/u/n/User%7EDuncan.france_d9ef.html" title="User:Duncan.france">Duncan.france</a>, <a href="../../../p/i/n/User%7EPinball22_a948.html" title="User:Pinball22">Pinball22</a>, RobertG, <a href="../../../m/a/r/User%7EMargosbot_a231.html" title="User:Margosbot">Margosbot</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a>, <a href="../../../t/o/m/User%7ETommyBoy_c06c.html" title="User:TommyBoy">TommyBoy</a>, <a href="../../../p/a/x/User%7EPaxsimius_2f84.html" title="User:Paxsimius">Paxsimius</a>, <a href="../../../i/n/k/User%7EInky_f579.html" title="User:Inky">Inky</a>, <a href="../../../p/e/t/User%7EPetersam_7af3.html" title="User:Petersam">Petersam</a>, <a href="../../../j/n/i/User%7EJni_807c.html" title="User:Jni">Jni</a>, <a href="../../../b/o/o/User%7EBoothy443_59af.html" title="User:Boothy443">Boothy443</a>, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a>, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../o/f/f/User%7EOfficiallyover_61b0.html" title="User:Officiallyover">Officiallyover</a>, <a href="../../../p/h/i/User%7EPhilipc_cfc7.html" title="User:Philipc">Philipc</a>, <a href="../../../m/r/s/User%7EMrSmart_df2d.html" title="User:MrSmart">MrSmart</a>, <a href="../../../n/m/a/User%7ENma_wiki_d498.html" title="User:Nma wiki">Nma wiki</a>, <a href="../../../x/e/v/User%7EXevi_3d02.html" title="User:Xevi">Xevi</a>, <a href="../../../s/t/e/User%7EStewartadcock_c102.html" title="User:Stewartadcock">Stewartadcock</a>, <a href="../../../j/a/c/User%7EJackofOz_7cdf.html" title="User:JackofOz">JackofOz</a>, <a href="../../../k/e/4/User%7EKe4roh_a96d.html" title="User:Ke4roh">Ke4roh</a>, <a href="../../../t/a/o/User%7ETaoster_305c.html" title="User:Taoster">Taoster</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../l/i/v/User%7ELivajo_e5ea.html" title="User:Livajo">Livajo</a>, <a href="../../../h/a/d/User%7EHadal_a4d0.html" title="User:Hadal">Hadal</a>, <a href="../../../y/o/s/User%7EYosri_d93e.html" title="User:Yosri">Yosri</a>, <a href="../../../g/u/a/User%7EGuanabot_b902.html" title="User:Guanabot">Guanabot</a>, <a href="../../../z/o/c/User%7EZocky_c719.html" title="User:Zocky">Zocky</a>, <a href="../../../t/h/e/User%7EThe_Anome_61a9.html" title="User:The Anome">The Anome</a>, <a href="../../../e/m/p/User%7EEmperorbma_7b7a.html" title="User:Emperorbma">Emperorbma</a>, <a href="../../../d/a/n/User%7EDan_aka_jack_ed76.html" title="User:Dan aka jack">Dan aka jack</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../n/u/n/User%7ENunh-huh_d05a.html" title="User:Nunh-huh">Nunh-huh</a>, <a href="../../../c/h/r/User%7EChris_Ducat_bf96.html" title="User:Chris Ducat">Chris Ducat</a>, <a href="../../../i/l/u/User%7EIluvcapra_8a8a.html" title="User:Iluvcapra">Iluvcapra</a>, <a href="../../../w/m/a/User%7EWmahan_ede0.html" title="User:Wmahan">Wmahan</a>, ThePhantom, <a href="../../../h/e/h/User%7EHehelol_04be.html" title="User:Hehelol">Hehelol</a>, Jasper Chua, <a href="../../../e/d/h/User%7EEdH_fee0.html" title="User:EdH">EdH</a>, <a href="../../../g/i/n/User%7EGingekerr_8f0d.html" title="User:Gingekerr">Gingekerr</a>, <a href="../../../r/a/d/User%7ERadicalBender_a5e1.html" title="User:RadicalBender">RadicalBender</a>, <a href="../../../t/o/n/User%7ETonyClarke_b748.html" title="User:TonyClarke">TonyClarke</a>, <a href="../../../n/i/k/User%7ENikai_7c15.html" title="User:Nikai">Nikai</a>, <a href="../../../w/i/k/User%7EWikibot_9002.html" title="User:Wikibot">Wikibot</a>, Edbeckham, <a href="../../../t/e/d/User%7ETedius_Zanarukando_3729.html" title="User:Tedius Zanarukando">Tedius Zanarukando</a>, <a href="../../../t/r/i/User%7ETristanb_d761.html" title="User:Tristanb">Tristanb</a>, <a href="../../../j/o/s/User%7EJose_Ramos_c07e.html" title="User:Jose Ramos">Jose Ramos</a>, <a href="../../../c/f/e/User%7ECferrero_3327.html" title="User:Cferrero">Cferrero</a>, <a href="../../../j/t/d/User%7EJtdirl_d3f0.html" title="User:Jtdirl">Jtdirl</a>, <a href="../../../c/h/r/User%7EChristian_3dad.html" title="User:Christian">Christian</a>, <a href="../../../c/h/a/User%7EChadloder_f409.html" title="User:Chadloder">Chadloder</a> and <a href="../../../m/a/v/User%7EMaveric149_24ee.html" title="User:Maveric149">Maveric149</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
